var title_f32_26_33184="2 D views coronary perfusion";
var content_f32_26_33184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Relationship of two dimensional views and coronary artery perfusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 386px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The location of culprit coronary lesions can be inferred from the location of echocardiographic segmental abnormalities.",
"    <div class=\"footnotes\">",
"     LAD: left anterior descending artery; Prox: proximal; LCX: left circumflex artery; RCA: right coronary artery; PDA: posterior descending artery.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Feigenbaum, H, J Amer Soc Echo, 1988; 1:165.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33184=[""].join("\n");
var outline_f32_26_33184=null;
var title_f32_26_33185="Laser PRP for severe PDR";
var content_f32_26_33185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F77583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F77583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Panretinal photocoagulation for severe proliferative diabetic retinopathy: Appearance on fundus photograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color fundus photograph of the posterior portion of laser panretinal photocoagulation (PRP) for severe proliferative diabetic retinopathy with areas of neovascularization at the disc and elsewhere (NVD and NVE) as well as white ischemic retinal vessels, and displaying numerous laser burns outside the macula; the treatment would further continue in all quadrants to the midperiphery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33185=[""].join("\n");
var outline_f32_26_33185=null;
var title_f32_26_33186="Patient information: Age-related hearing loss (presbycusis) (The Basics)";
var content_f32_26_33186=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16547\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/61/30677\">",
"         Normal ear",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?43/38/44642\">",
"         Patient information: Ear infections (otitis media) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?15/2/15394\">",
"         Patient information: Outer ear infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/26/43425\">",
"         Patient information: Tinnitus (ringing in the ears) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?26/12/26816\">",
"         Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/42/18082\">",
"         Patient information: Tinnitus (ringing in the ears) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Age-related hearing loss (presbycusis) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/age-related-hearing-loss-presbycusis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H24673197\">",
"      <span class=\"h1\">",
"       What is age-related hearing loss?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When people talk about age-related hearing loss, they are usually referring to a condition called &ldquo;presbycusis.&rdquo; This condition becomes more common with age. It affects more than half of all adults by the time they reach the age of 75. &nbsp;",
"     </p>",
"     <p>",
"      Presbycusis causes you to slowly lose your hearing in both ears. It mostly affects how well you hear high pitched sounds. That means that a person with presbycusis might have trouble hearing a bird chirping or a phone ringing but still be able to hear a truck rumbling. Also, people with presbycusis often find that they have a hard time hearing in crowded places.",
"     </p>",
"     <p>",
"      Presbycusis is just one form of hearing loss that happens as you age. There are other conditions that affect hearing that also become more common with age. The most common of these is a condition called tinnitus, which causes you to hear ringing, buzzing, hissing, or roaring in one or both ears. Often presbycusis and tinnitus occur together.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673212\">",
"      <span class=\"h1\">",
"       What causes hearing loss?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When doctors refer to hearing loss, they often talk about:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Sensorineural hearing loss",
"        </strong>",
"        &ndash; This type of hearing loss happens when structures in the ear that register sounds and send signals to the brain are damaged. These structures are found deep in the ear in a part called the &ldquo;inner ear&rdquo; (",
"        <a class=\"graphic graphic_figure graphicRef55121 \" href=\"mobipreview.htm?29/61/30677\">",
"         figure 1",
"        </a>",
"        ). Presbycusis is a type of sensorineural hearing loss.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Conductive hearing loss",
"        </strong>",
"        &ndash; This type of hearing loss happens when sounds can&rsquo;t get to the inner ear because of problems in the middle or outer ear. For example, conductive hearing loss can happen if you have too much wax in your ear, and sounds are being muffled. It can also happen if you have an ear infection and parts of your ear are swollen or filled with fluid.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Mixed hearing loss",
"        </strong>",
"        &ndash; Mixed hearing loss happens when both types of hearing loss mentioned above occur at the same time. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673228\">",
"      <span class=\"h1\">",
"       What other symptoms should I watch for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you develop sudden hearing loss, look for important signs, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Dizziness",
"       </li>",
"       <li>",
"        Fluid coming from your ears",
"       </li>",
"       <li>",
"        Feeling as though your ears are &ldquo;full&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673243\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you have any of the above symptoms or if your hearing loss does not go away or gets worse.",
"     </p>",
"     <p>",
"      Your doctor or nurse will ask about your hearing loss and about the medicines you take now and have taken. That&rsquo;s because some medicines can cause hearing problems. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673258\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will probably start by looking inside your ear using a special tool called an &ldquo;otoscope.&rdquo; That way, he or she can check if anything looks swollen, blocked, torn or infected. Then your doctor or nurse will decide which tests you should have based on your age, your medical history, other symptoms, and your physical exam. If he or she suspects hearing loss, you will probably need a test called an &ldquo;audiogram.&rdquo;",
"     </p>",
"     <p>",
"      A hearing specialist, called an &ldquo;audiologist,&rdquo; will do the audiogram. To do the test, you put on a headset. Then the audiologist plays sounds in one ear at a time and asks you to indicate when you hear the sounds. This test will show how severe your hearing loss is and whether both ears are affected the same way.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673273\">",
"      <span class=\"h1\">",
"       How is hearing loss treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have presbycusis, your ear doctor (called an &ldquo;otolaryngologist&rdquo;) will probably recommend hearing aids. But if you have other hearing problems, too, they might need different treatments. For instance, if you have too much wax in your ears, your doctor or nurse can teach you how to get the wax out. And if you have ringing or buzzing in your ears because of tinnitus, you might need to learn special skills to manage that problem.",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Hearing aids",
"        </strong>",
"        &ndash; You might not want to wear hearing aids because they make you feel embarrassed, or because you think they don&rsquo;t work. If your doctor recommends them, try to keep an open mind, even if you have tried them in the past. Hearing aid technology has gotten a lot better. There are now lots of different types of hearing aids to try. It might take a few tries to find the right type of aid and the right settings, but hearing aids can really help. The key is to work with your ear doctor until you find the best option for you. Always tell him or her if you have problems with the way your hearing aids sound or fit. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673288\">",
"      <span class=\"h1\">",
"       Can hearing loss be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some forms of hearing loss can be prevented. To protect your hearing, the most important thing you can do is avoid loud noises. If you must be around loud noises, then wear ear plugs or head phones that will protect your ears.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24673303\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/26/43425?source=see_link\">",
"       Patient information: Tinnitus (ringing in the ears) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/2/15394?source=see_link\">",
"       Patient information: Outer ear infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/38/44642?source=see_link\">",
"       Patient information: Ear infections (otitis media) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/42/18082?source=see_link\">",
"       Patient information: Tinnitus (ringing in the ears) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/12/26816?source=see_link\">",
"       Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/26/33186?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16547 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33186=[""].join("\n");
var outline_f32_26_33186=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673197\">",
"      What is age-related hearing loss?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673212\">",
"      What causes hearing loss?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673228\">",
"      What other symptoms should I watch for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673243\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673258\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673273\">",
"      How is hearing loss treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673288\">",
"      Can hearing loss be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24673303\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16547\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/61/30677\">",
"      Normal ear",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/38/44642?source=related_link\">",
"      Patient information: Ear infections (otitis media) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/12/26816?source=related_link\">",
"      Patient information: External otitis (including swimmer's ear) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/2/15394?source=related_link\">",
"      Patient information: Outer ear infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/42/18082?source=related_link\">",
"      Patient information: Tinnitus (ringing in the ears) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/26/43425?source=related_link\">",
"      Patient information: Tinnitus (ringing in the ears) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_26_33187="Sexual maturity rating of pubic hair in boys";
var content_f32_26_33187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sexual maturity rating (Tanner staging) of pubic hair development in boys",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 542px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stages of pubic hair development in boys. Stage 1: Prepubertal, with no pubic hair. Stage 2: Sparse, straight pubic hair along the base of the penis. Stage 3: Hair is darker, coarser, and curlier, extending over the mid-pubis. Stage 4: Hair is adult-like in appearance, but does not extend to thighs. Stage 5: Hair is adult in appearance, extending from thigh to thigh.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figure from: Roede MJ, van Wieringen JC. Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschr Soc Gezondheids 1985; 63:1. Reproduced with permission from the author.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33187=[""].join("\n");
var outline_f32_26_33187=null;
var title_f32_26_33188="Schatzki ring healed CPC Endosc";
var content_f32_26_33188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66882%7EGAST%2F75853%7EGAST%2F82313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66882%7EGAST%2F75853%7EGAST%2F82313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schatzki's ring healed",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic view of the distended distal esophagus revealing complete healing of the superficial ulceration with a ring of thin membrane occluding 70 percent of the distal esophageal lumen. This is the characteristic endoscopic view of a Schatzki ring.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres Gelrud, MD and Douglas A. Horst, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schatzki ring dilation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic imaging showing balloon dilation of the distal esophageal ring.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres Gelrud, MD and Douglas A. Horst, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schatzki ring following balloon dilation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A wider distal esophageal lumen without the ring and a small amount of bleeding is seen following balloon dilation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres Gelrud, MD and Douglas A. Horst, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33188=[""].join("\n");
var outline_f32_26_33188=null;
var title_f32_26_33189="Darunavir: Patient drug information";
var content_f32_26_33189=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Darunavir: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     see \"Darunavir: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3020778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Prezista&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F7828263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Prezista&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat HIV infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to darunavir, ritonavir, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are",
"       <b>",
"        not",
"       </b>",
"       taking ritonavir.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697269",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697271",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high triglycerides, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697233",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an irritated pancreas, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use a hormone-related kind of birth control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696711",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not breast-feed if you have HIV disease unless your doctor tells you to.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High cholesterol level.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698150",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High triglyceride level.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697937",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in body fat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698299",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pancreatitis may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3762724",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water or milk.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705867",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Measure liquid doses carefully. Use the measuring device that comes with this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3762730",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking 1 time a day and it is more than 12 hours until your next dose, take the missed dose right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3762731",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking 1 time a day and it is less than 12 hours to your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3762732",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking 2 times a day and it is more than 6 hours to your next dose, take the missed dose right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3762733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking 2 times a day and it is less than 6 hours to your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11616 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-A277839E2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33189=[""].join("\n");
var outline_f32_26_33189=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3020778\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7828263\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027082\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027084\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027083\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027088\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027089\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027091\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027086\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027087\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027092\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027093\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=related_link\">",
"      Darunavir: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_26_33190="Pathogenesis of photoaging";
var content_f32_26_33190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of photoaging",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This diagram demonstrates the effects of UV irradiation on the skin. UV radiations activate growth factor and cytokine receptors, which induce transcription factor AP-1, resulting in the upregulation of matrix metalloproteinase (MMP) genes. AP-1 also disturbs procollagen gene expression. The end results are dermal matrix breakdown and decreased collagen synthesis. The cumulative effect of repeated UV injury determines the clinical features seen in photoaged skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462. Copyright &copy; 2002 American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33190=[""].join("\n");
var outline_f32_26_33190=null;
var title_f32_26_33191="Omalizumab mechansim";
var content_f32_26_33191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F59320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F59320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Omalizumab mechanism of action",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 646px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Omalizumab binds free IgE in the serum, forming trimers and hexamers. The drug binds to IgE at the same site that the high-affinity IgE receptor (Fc-epsilon-RI) binds, so IgE bound to drug cannot bind its receptor on mast cells and basophils. Omalizumab does not bind IgE that is already bound to Fc-epsilon-RI, and so should not result in cross-linking of receptors. As a result of the binding of free IgE, the number of IgE receptors on the surface of mast cells and basophils declines over time, which is believed to be a critical component of the clinical effect of the drug. Omalizumab also blocks binding of IgE to the low affinity IgE receptor (Fc-epsilon-RII or CD23, not shown) although the therapeutic relevance of this is not known.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33191=[""].join("\n");
var outline_f32_26_33191=null;
var title_f32_26_33192="Preventive dental care and counseling for infants and young children";
var content_f32_26_33192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Preventive dental care and counseling for infants and young children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Arthur J Nowak, DMD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     John J Warren, DDS, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Ann Griffen, DDS, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33192/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/26/33192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many oral health problems, including dental caries, malocclusion, and fluorosis, begin in childhood and can be prevented through regular preventive dental care and counseling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1\">",
"     1",
"    </a>",
"    ]. Despite the decrease in prevalence of dental caries among school-aged children from approximately 75 percent in the 1970s to 42 percent in 1999 to 2002 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/2\">",
"     2",
"    </a>",
"    ], caries continues to be one of the most common infectious diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. A Centers for Disease Control and Prevention report confirmed that tooth decay in primary teeth of children aged two to five years increased from 24 to 28 percent between 1988 to 1994 and 1999 to 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/9\">",
"     9",
"    </a>",
"    ]. The oral health goals for Healthy People 2020 include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decrease the proportion of three- to five-year-olds with caries in the primary dentition from 33 percent (1999 to 2004) to 30 percent",
"     </li>",
"     <li>",
"      Decrease the proportion of six- to nine-year-old children with caries in the mixed dentition from 54 percent (1999 to 2004) to 49 percent",
"     </li>",
"     <li>",
"      Decrease the proportion of adolescents with caries in the permanent dentition from 54 percent (1999-2004) to 48 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The provision of preventive dental care and counseling at regularly scheduled health maintenance visits is essential to the achievement of these goals and will be discussed below. Oral health habits are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19320?source=see_link\">",
"     \"Oral habits and orofacial development in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dental risk assessment before one year of age can help to identify children who are at risk for development of dental disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. Risk factors for the development of dental disease have been identified in several prospective studies and include findings from both the history and examination. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, infants who were from a lower socioeconomic environment, were born to mothers with lower education levels, consumed sugary beverages and candy, and had high salivary concentrations of",
"      <em>",
"       Streptococcus mutans",
"      </em>",
"      were 32 times more likely to have caries at age 3.5 years than were those without these risk factors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study followed 128 infants for a period of 18 months and found that consumption of sugar-sweetened beverages and presence of",
"      <em>",
"       S. mutans",
"      </em>",
"      during infancy were predictive of 18-month caries incidence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another prospective study of 92 19-month-old children, 83 percent of children with visible plaque on the outer surface of the upper front teeth developed caries within the following 18 months, and 92 percent of the children without such lesions remained caries-free during the same time period [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a fourth study of 3000 18-month-old children, those who continued to be breast-fed had a higher prevalence of caries than did those who no longer breast-fed (20 versus 2 percent); children with caries had a greater tendency to establish cariogenic dietary habits than did those who did not have caries, whether or not they were breast-fed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the increased risk of development of caries and other oral health problems, children with the following risk factors should be referred for early dental evaluation, preventive care, and counseling:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prolonged breast-feeding or bottle-feeding (&gt;12 months)",
"     </li>",
"     <li>",
"      Frequent consumption of sugary beverages and snacks",
"     </li>",
"     <li>",
"      Prolonged use of a training cup (sippy cup) throughout the day",
"     </li>",
"     <li>",
"      Use of a bottle at bed time",
"     </li>",
"     <li>",
"      Use of liquid medication for longer than three weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Insufficient fluoride exposure",
"     </li>",
"     <li>",
"      Visible plaque on upper front teeth",
"     </li>",
"     <li>",
"      Enamel pits or defects",
"     </li>",
"     <li>",
"      Exposure to passive tobacco smoke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with special health care needs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SCREENING EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric primary care providers should begin performing a dental screening examination as soon as the first teeth erupt, usually when the child is between five and eight months of age (",
"    <a class=\"graphic graphic_figure graphicRef51028 \" href=\"mobipreview.htm?41/33/42525\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The equipment necessary for this examination includes a light source, disposable mouth mirror, and a soft-bristled toothbrush. The examination may be conducted on the examination table or in the \"knee-to-knee\" position (",
"    <a class=\"graphic graphic_picture graphicRef50042 \" href=\"mobipreview.htm?7/21/7505\">",
"     picture 1",
"    </a>",
"    ). In the \"knee-to-knee\" position, the child is well supported and stable, the child's mouth is visible and accessible to the examiner, and the parent can support and distract the child.",
"   </p>",
"   <p>",
"    The goals of the screening dental examination include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Evaluation for abnormalities of teeth and oral mucosa (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30216?source=see_link\">",
"       \"Soft tissue lesions of the oral cavity in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Assessment for dental plaque",
"     </li>",
"     <li>",
"      Assessment for white spots",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cavities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With gloved hands and a good light source, the examiner should lift the child's upper lip to inspect the teeth for plaque. The teeth should be cleaned with a wet toothbrush, using a gentle scrubbing motion to remove plaque if it is present. After cleaning, the front surfaces of the teeth should be inspected for white spots, pitted enamel, stains, and cavities (",
"    <a class=\"graphic graphic_picture graphicRef73374 \" href=\"mobipreview.htm?22/41/23186\">",
"     picture 2",
"    </a>",
"    ). The back surfaces of the front teeth should be checked with the mouth mirror.",
"   </p>",
"   <p>",
"    If obvious decay, abscess, or other significant disease is noted during screening, the child should have an immediate referral to a dentist experienced in caring for children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DENTAL REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children should receive a dental referral at or near their first birthday. However, if dental providers in the area are unwilling to see children who are younger than three years of age, the pediatric health-care provider may continue to provide preventive dental care and counseling for infants and children who are at low risk of developing dental disease and have no abnormalities on screening examination. Children with risk factors for caries",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abnormalities on screening examination should be referred preferably to a pediatric dentist who accepts infants and toddlers. The American Academy of Pediatric Dentistry (AAPD) provides a Web site to help find a pediatric dentist (",
"    <a class=\"external\" href=\"file://www.aapd.org/finddentist\">",
"     www.aapd.org/finddentist",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Making a dental referral provides the pediatric care provider with an opportunity to explain the concept of the dental home and encourage the parents to establish one as soon as possible after the first birthday, and certainly by the time the child is three years of age. Once the referral is made, pediatric and dental care providers should communicate regarding the child's diagnosis and treatment plans. The pediatric care provider should verify that the child kept the initial appointment and continues to be seen by the dentist at least annually. The pediatric care provider should continue to provide oral health anticipatory guidance at regularly scheduled health maintenance visits. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Dental home'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8\">",
"     'Anticipatory guidance'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     First dental visit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAPD, the American Dental Association (ADA), the American Public Health Association, and the American Academy of Pediatrics (AAP) recommend that the first dental visit occur at or near one year of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1,18,19\">",
"     1,18,19",
"    </a>",
"    ]. We support the recommendation for initiation of dental care as soon as possible after the child's first birthday, particularly for children who are at risk for development of oral health problems.",
"   </p>",
"   <p>",
"    The rationale for the early dental visit centers on the early initiation of preventive care and counseling, including evaluation of dental risks (ie, caries, malocclusion) and anticipatory guidance regarding dental hygiene, fluoride, diet, dietary habits, and oral habits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. In addition, early dental referral can provide a pleasant, nonthreatening introduction to the dentist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19320?source=see_link\">",
"     \"Oral habits and orofacial development in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The potential benefits of early initiation of dental care were demonstrated in one study in which an oral examination and comprehensive preventive dental program (including monitoring of oral bacteria and referral for dental treatment if needed) were provided to 36 pregnant women who delivered 47 children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/11\">",
"     11",
"    </a>",
"    ]. After delivery, the mothers were instructed on how to care for their infants' teeth (eg, brushing, use of fluoride toothpaste, dietary habits), and professional examinations were provided to the mothers and children every six months until the children were four years of age. When the children were three and four years of age, the study group was compared with an age-matched control group who received neither pre- nor postnatal dental care. The oral health of the study group at four years of age was better than that of the control group, as indicated by the following parameters:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Naturally healthy dentition (91 versus 58 percent in the study and control groups, respectively)",
"     </li>",
"     <li>",
"      Presence of caries (9 versus 42 percent)",
"     </li>",
"     <li>",
"      Mean decayed, missing, filled teeth score (DMF-s) (1.5 versus 7.0)",
"     </li>",
"     <li>",
"      <em>",
"       S. mutans",
"      </em>",
"      score &ge;2 (&gt;10",
"      <sup>",
"       5",
"      </sup>",
"      colony-forming units",
"      <span class=\"nowrap\">",
"       (cfu)/mL)",
"      </span>",
"      (21 percent versus 60 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the evidence of the potential benefits of early dental care, the recommendation of the ADA for the first dental visit at 12 months of age has been slow, but has improved since 2003. Several factors have contributed to the slow adoption of this recommendation, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many pediatric providers follow the recommendations of the AAP, which, until 2003, identified three years as the preferred age for dental referral [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/24\">",
"       24",
"      </a>",
"      ]. In 2003, the AAP Section on Pediatric Dentistry issued a policy statement recommending establishment of a dental home by one year of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1\">",
"       1",
"      </a>",
"      ]. The AAP now recommends oral health risk assessment beginning at six months and referral to a dental home (if available) at 12, 18, 24, and 30 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many dentists are not willing to provide dental care to one-year-old children. National data are lacking, but reports from Texas and Iowa during the 1990s found that only about one-fourth of dentists would provide dental examinations to one-year-old children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. More recent data from Iowa indicate that 53 percent of dentists will accept a child from birth to 23 months and 74 percent would accept children from 24 to 35 months old [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/27\">",
"       27",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In a 1996 survey, only 47 percent of pediatric dentists surveyed performed the first dental evaluation in children at or before 12 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/28\">",
"       28",
"      </a>",
"      ]. In 2009, 89 percent scheduled asymptomatic children younger than 24 months old [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/29\">",
"       29",
"      </a>",
"      ]. In a 2012 follow-up study, 90 percent of the pediatric dentists who responded perform infant oral evaluations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Additional reasons include reimbursement, busy schedules, inexperience in providing dental care to young children, and parental apathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Dental home",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dental home, similar to the medical home that is recommended by the AAP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/31-33\">",
"     31-33",
"    </a>",
"    ], should be established at the initial dental examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/34\">",
"     34",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=see_link&amp;anchor=H16#H16\">",
"     \"Children with special health care needs\", section on 'Medical home'",
"    </a>",
"    ). The dental home should provide the following services:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Initial dental visit at 12 to 18 months of age",
"     </li>",
"     <li>",
"      Risk assessment for dental disease",
"     </li>",
"     <li>",
"      Evaluation of fluoride needs",
"     </li>",
"     <li>",
"      Demonstration of appropriate teeth-cleaning method",
"     </li>",
"     <li>",
"      Discussion of the benefits and risks of nonnutritive sucking",
"     </li>",
"     <li>",
"      Monitoring of the child's oral health care on a schedule that is individualized to the child's risk for dental disease",
"     </li>",
"     <li>",
"      Treatment (or referral for treatment) of dental caries",
"     </li>",
"     <li>",
"      24-hour availability for acute dental problems",
"     </li>",
"     <li>",
"      Recognition of the need for specialty consultation and referrals",
"     </li>",
"     <li>",
"      Provision of continuing, comprehensive dental care for all children, including those with special health care needs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ANTICIPATORY GUIDANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pediatric care provider should provide and reinforce dental anticipatory guidance at regularly scheduled health maintenance visits. Before the eruption of the child's primary dentition, the provider can discuss nonnutritive sucking and the teething process. The need for fluoride supplementation should be evaluated before the six-month check-up so that, if it is necessary, it can be initiated at the six-month visit (",
"    <a class=\"graphic graphic_table graphicRef69038 \" href=\"mobipreview.htm?30/16/30987\">",
"     table 1",
"    </a>",
"    ). Feeding habits, the use of the bottles and cups, and cleaning the teeth become more important as the primary dentition erupts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Nonnutritive sucking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonnutritive sucking is a normal part of early development; it is self-soothing behavior that occurs in 70 to 90 percent of infants in various populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/33,35-37\">",
"     33,35-37",
"    </a>",
"    ]. The frequency of sucking on digits or pacifiers decreases with increasing age; by the age of four to five years, nonnutritive sucking is usually replaced by other coping mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/35\">",
"     35",
"    </a>",
"    ]. Compared with pacifier sucking, digit sucking is more likely to persist into the fourth or fifth year of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. If it persists into the period of permanent tooth eruption, nonnutritive sucking may contribute to the development of malocclusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/40\">",
"     40",
"    </a>",
"    ]. The dental effects and recommendations for the discontinuation of sucking habits are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19320?source=see_link&amp;anchor=H2#H2\">",
"     \"Oral habits and orofacial development in children\", section on 'Nonnutritive sucking'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Teething",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is normal for infants whose primary teeth are erupting to be cranky, chew on objects, and have excessive drooling. Parents frequently report that their teething infants have fever, diarrhea, or other systemic symptoms; however, no proven association exists between these symptoms and teething [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/41-45\">",
"     41-45",
"    </a>",
"    ]. The management of teething symptoms is palliative (eg, chewing on a chilled teething ring or other teething device, oral analgesia). The benefit of topical gels in managing teething pain has not been demonstrated. Because of the risk of methemoglobinemia, over-the-counter teething products that contain",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/19/11574?source=see_link\">",
"     benzocaine",
"    </a>",
"    should not be used in children younger than two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39590?source=see_link&amp;anchor=H11#H11\">",
"     \"Anatomy and development of the teeth\", section on 'Teething symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Oral hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parents should be encouraged to clean the child's teeth at least daily when the child is between 6 and 24 months of age, and twice a day thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/10\">",
"     10",
"    </a>",
"    ]. The teeth may be cleaned with a small soft toothbrush. To avoid fluorosis, fluoride-containing toothpaste should be used in very small amounts, working up to a \"pea-sized\" amount of toothpaste during the later preschool years. Parents should supervise toothbrushing at least until the child is five to six years old or can tie shoelaces. Flossing should be initiated when the space between teeth becomes too small to clean adequately with a toothbrush.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Dietary habits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticipatory guidance regarding diet and dietary habits can play a major role in the prevention of caries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/10\">",
"     10",
"    </a>",
"    ]. The acid that is produced when the bacteria in plaque metabolize carbohydrates decreases the pH of the oral cavity. Saliva is able to buffer the acid until the oral pH is less than 5.5; at this pH, demineralization of the dental enamel occurs. With continued exposure to pH &lt;5.5 (eg, from constant snacking or grazing), the surface enamel develops a chalky texture, known as the white spot lesion (",
"    <a class=\"graphic graphic_picture graphicRef73374 \" href=\"mobipreview.htm?22/41/23186\">",
"     picture 2",
"    </a>",
"    ). At this stage, teeth cleaning, plaque removal, and the use of topical fluoride promote remineralization; without intervention, cavitation will result.",
"   </p>",
"   <p>",
"    In vitro, human breast milk, formula, and other beverages differ in their ability to support bacterial growth, dissolve enamel mineral, reduce plaque pH, buffer acid, and decalcify enamel and dentin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Compared with water, breast milk and most infant formulas reduce plaque pH, have variable buffering capacity, and may support bacterial growth and dissolve enamel mineral when exposure is prolonged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Other beverages, such as juices that are commonly given to infants and toddlers in bottles or training cups, have high cariogenic potential (",
"    <a class=\"graphic graphic_table graphicRef67883 \" href=\"mobipreview.htm?5/37/5725\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/10\">",
"     10",
"    </a>",
"    ]. These beverages should not be consumed in bed, should be offered only from a training cup, and should not be sipped throughout the day. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10938?source=see_link&amp;anchor=H16#H16\">",
"     \"Introducing solid foods and vitamin and mineral supplementation during infancy\", section on 'Fruit juice'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cariogenic potential is increased in foods that have a high carbohydrate content, decrease the pH of the oral cavity, and are slowly cleared from the mouth (eg, raisins, peanut butter). Avoiding such foods altogether may not be necessary provided the teeth are cleaned appropriately after their ingestion. Moderation is the key word, followed by frequency, and finally duration. It is commonly suggested that children ingest sugary foods with a meal as desserts, rather than being allowed to snack or \"graze\" on such food throughout the day.",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics recommends that infants be breast-fed exclusively for the first six months of life, that breastfeeding continue until the child is one year of age, and that solid foods be introduced at approximately six months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/50\">",
"     50",
"    </a>",
"    ]. The use of a training cup for juice and other beverages can begin as soon as the child is able to drink from one (at approximately six months of age), and bottles should be discontinued as soon as possible after the child reaches one year of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/51\">",
"     51",
"    </a>",
"    ]. Fruit juice should be consumed only at meals, and carbonated beverages, particularly those sweetened with sugar or corn syrup, should be avoided for the first 30 months of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10938?source=see_link&amp;anchor=H16#H16\">",
"     \"Introducing solid foods and vitamin and mineral supplementation during infancy\", section on 'Fruit juice'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breast-feeding has been suggested to reduce the risk of malocclusion. However, few studies have evaluated the effects of infant feeding method on dental arch development. Those that have been performed are inconclusive because they relied on parental report or cursory assessment of malocclusion, rather than actual measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. Thus, the effects of breast- or bottle-feeding on dental arch development are largely unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fluoride",
"    </span>",
"    &nbsp;&mdash;&nbsp;To avoid the risk of dental caries from too little fluoride or fluorosis from too much, an accurate assessment of the child's fluoride intake must be made. It is particularly important to monitor the child's fluoride intake during the critical months of enamel maturation (up to 48 months), when the developing anterior permanent teeth are most vulnerable to excessive fluoride that can cause fluorosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fluoride supplementation, if indicated based upon fluoride intake and caries risk, should begin at six months of age (",
"    <a class=\"graphic graphic_table graphicRef69038 \" href=\"mobipreview.htm?30/16/30987\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/57\">",
"     57",
"    </a>",
"    ]. Fluoride supplementation is only necessary if the child is at high risk for caries and other fluoride vehicles (fluoride toothpaste or mouth rinses) have proved to be inadequate, and the family is using nonfluoridated water, bottled or processed waters, or water from a rural well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most bottled water products contain negligible levels of fluoride, although the content varies. In one study, the fluoride concentration in bottled water ranged from &lt;0.1 to 0.94",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef60261 \" href=\"mobipreview.htm?19/46/20203\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/59\">",
"     59",
"    </a>",
"    ]. Only 6 of the 54 brands tested contained more than 0.25",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    of fluoride.",
"   </p>",
"   <p>",
"    The treatment of water before drinking may affect the fluoride concentration. Faucet water filters that use reverse osmosis systems and distillation units reduce the fluoride content by more than 80 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Some, but not all, studies of \"pour-through\" devices using activated carbon filters demonstrate a reduction of fluoride content [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. Water and conditioning softener systems do not alter fluoride content [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/60,63,64\">",
"     60,63,64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Fluorosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess fluoride consumption (generally greater than 0.05",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) can cause fluorosis or hypomineralization of the dental enamel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/65\">",
"     65",
"    </a>",
"    ]. According to data from the National Health and Nutrition Examination Survey, the prevalence of fluorosis among persons aged 6 to 39 years was 23 percent during 1999 to 2002 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fluorosis is primarily a cosmetic concern, but it can make the teeth more susceptible to wear and breakage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/66\">",
"     66",
"    </a>",
"    ]. Mild fluorosis is indicated by a white flecked or lacy appearance to the enamel (",
"    <a class=\"graphic graphic_picture graphicRef63417 \" href=\"mobipreview.htm?21/4/21583\">",
"     picture 3",
"    </a>",
"    ); severe fluorosis is indicated by a brown discoloration. The mechanism by which excessive fluoride consumption causes fluorosis is not fully understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Fluorosis can be prevented by limitation of excessive fluoride consumption (eg, through the swallowing of fluoridated toothpaste or mouth rinses) early in life and appropriate fluoride supplementation.",
"   </p>",
"   <p>",
"    A prospective study found that using optimally fluoridated water to reconstitute powdered infant formula concentrate increased the risk of dental fluorosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/69\">",
"     69",
"    </a>",
"    ]. As a result of this and other similar observations, the American Dental Association&rsquo;s Council on Scientific Affairs recommends that clinicians be cognizant of this risk in counseling parents regarding the use of infant formulas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly one-half of children sustain some type of dental injury during childhood. Many of these injuries are preventable through anticipatory guidance regarding prevention of falls, particularly when the child is learning to walk. As the child begins to participate in sports and recreation activities that are associated with a risk of dental trauma, parents and children should be counseled about the use of protective gear (eg, facemasks and mouthguards) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33192/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, parents should be instructed regarding the proper management of avulsed primary and permanent teeth, as well as the importance of regular dental care and maintenance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32489?source=see_link\">",
"     \"Evaluation and management of dental injuries in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DENTAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following resources may provide useful oral health information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.aapd.org/\">",
"       The American Academy of Pediatric Dentistry",
"      </a>",
"      provides information and resources including",
"      <a class=\"external\" href=\"file://www.aapd.org/finddentist/\">",
"       help finding a pediatric dentist",
"      </a>",
"      <br/>",
"      <br/>",
"      (312) 337-2169&nbsp;",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ada.org/\">",
"       American Dental Association",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; (312) 440-2500",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.mchoralhealth.org/\">",
"       Office of Maternal and Child Health (DHHS)",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; (202) 784-9771",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.nidcr.nih.gov/\">",
"       National Institute of Dental and Craniofacial Research",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; (301) 496-4261",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.mchoralhealth.org/knwpathoralhealth.html\">",
"       Maternal and Child Health Library",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.mchoralhealth.org/PediatricOH/index.htm\">",
"       A Health Professional's Guide to Pediatric Oral Health Management",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24949228\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dental risk assessment before one year of age can help to identify children who are at risk for development of dental disease. Children with the following risk factors should be referred for early dental evaluation, preventive care, and counseling (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Risk assessment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Prolonged breast-feeding or bottle-feeding (&gt;12 months)",
"     </li>",
"     <li>",
"      Frequent consumption of sugary beverages and snacks",
"     </li>",
"     <li>",
"      Prolonged use of a training cup (sippy cup) throughout the day",
"     </li>",
"     <li>",
"      Use of a bottle at bed time",
"     </li>",
"     <li>",
"      Use of liquid medication for longer than three weeks",
"     </li>",
"     <li>",
"      Insufficient fluoride exposure",
"     </li>",
"     <li>",
"      Visible plaque on upper front teeth",
"     </li>",
"     <li>",
"      Enamel pits or defects",
"     </li>",
"     <li>",
"      Exposure to passive tobacco smoke",
"     </li>",
"     <li>",
"      Children with special health care needs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric primary care providers should begin performing a dental screening examination for abnormalities of the teeth and oral mucosa (including dental plaque, white spots, and cavities) as soon as the first teeth erupt. If obvious decay, abscess, or other significant disease is noted during screening, the child should have an immediate referral to a dentist experienced in caring for children. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Screening examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All children should receive a dental referral at or near their first birthday. However, if dental providers in the area are unwilling to see young children, the pediatric clinician may continue to provide preventive dental care and counseling for infants and children who are at low risk of developing dental disease and have no abnormalities on screening examination. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Dental referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pediatric care provider should provide and reinforce dental anticipatory guidance at regularly scheduled health maintenance visits. Topics to be discussed include nonnutritive sucking, the teething process, oral hygiene, feeding habits (ie, the use of bottles and cups), the need for fluoride supplementation, and dental trauma. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Anticipatory guidance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/1\">",
"      Hale KJ, American Academy of Pediatrics Section on Pediatric Dentistry. Oral health risk assessment timing and establishment of the dental home. Pediatrics 2003; 111:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/2\">",
"      Beltr&aacute;n-Aguilar ED, Barker LK, Canto MT, et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveill Summ 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     NIDR: the prevalence of dental caries in United States children: The National Caries Prevalence Survey: 1979-1989. NIH Publication 82-2245. National Instutute of Dental Research, National Caries Program, 1981.",
"    </li>",
"    <li>",
"     Brunelle JA. Oral health of United States children: The National Survey of Dental Caries in US School Children: 1986-1987. NIH Publication 9-2247. National Institute of Dental Research, Epidemiology and Disease Prevention Program, 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/5\">",
"      Kelly JE, Harvey CR. Basic data on dental examination findings of persons 1-74 years. United States, 1971-1974. Vital Health Stat 11 1979; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/6\">",
"      Kaste LM, Selwitz RH, Oldakowski RJ, et al. Coronal caries in the primary and permanent dentition of children and adolescents 1-17 years of age: United States, 1988-1991. J Dent Res 1996; 75 Spec No:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/7\">",
"      Edelstein BL, Douglass CW. Dispelling the myth that 50 percent of U.S. schoolchildren have never had a cavity. Public Health Rep 1995; 110:522.",
"     </a>",
"    </li>",
"    <li>",
"     Healthy People 2020. Oral health. file://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicid=32 (Accessed on January 05, 2011).",
"    </li>",
"    <li>",
"     CDC National Center for Health Statistics. Trends in Oral Health Status: United States, 1988-1994 and 1999-2004. April 2007, Series 11, Number 248. p.104.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/10\">",
"      Section on Pediatric Dentistry and Oral Health. Preventive oral health intervention for pediatricians. Pediatrics 2008; 122:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/11\">",
"      G&uuml;nay H, Dmoch-Bockhorn K, G&uuml;nay Y, Geurtsen W. Effect on caries experience of a long-term preventive program for mothers and children starting during pregnancy. Clin Oral Investig 1998; 2:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/12\">",
"      Warren JJ, Weber-Gasparoni K, Marshall TA, et al. A longitudinal study of dental caries risk among very young low SES children. Community Dent Oral Epidemiol 2009; 37:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/13\">",
"      Alaluusua S, Malmivirta R. Early plaque accumulation--a sign for caries risk in young children. Community Dent Oral Epidemiol 1994; 22:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/14\">",
"      Hallonsten AL, Wendt LK, Mej&agrave;re I, et al. Dental caries and prolonged breast-feeding in 18-month-old Swedish children. Int J Paediatr Dent 1995; 5:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/15\">",
"      Maguire A, Rugg-Gunn AJ, Butler TJ. Dental health of children taking antimicrobial and non-antimicrobial liquid oral medication long-term. Caries Res 1996; 30:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/16\">",
"      Aligne CA, Moss ME, Auinger P, Weitzman M. Association of pediatric dental caries with passive smoking. JAMA 2003; 289:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/17\">",
"      Recommendations for preventive pediatric health care. Pediatrics 2007; 120:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/18\">",
"      Kohn DW. Dentists in a bubble. Pediatr Dent 1999; 21:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/19\">",
"      Ramos-Gomez F, Jue B, Bonta CY. Implementing an infant oral care program. J Calif Dent Assoc 2002; 30:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/20\">",
"      Caufield PW, Cutter GR, Dasanayake AP. Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993; 72:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/21\">",
"      Karn TA, O'Sullivan DM, Tinanoff N. Colonization of mutans streptococci in 8- to 15-month-old children. J Public Health Dent 1998; 58:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/22\">",
"      Herrmann HJ, Roberts MW. Preventive dental care: the role of the pediatrician. Pediatrics 1987; 80:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/23\">",
"      Twetman S, Garc&iacute;a-Godoy F, Goepferd SJ. Infant oral health. Dent Clin North Am 2000; 44:487.",
"     </a>",
"    </li>",
"    <li>",
"     Recommendations for preventive pediatric health care (RE9939). Pediatrics 2000; 105:645. Available at: www.aap.org/policy/re9939.html (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     Cotton KT, Seale NS, Damiano PC, et al. Predoctoral training: Can it affect general dentists' willingness to treat preschool aged children? Baylor College of Dentistry, Dallas 1999 (unpublished).",
"    </li>",
"    <li>",
"     Damiano PC, Kanellis MJ, Willard JC, et al. A report on the Iowa Title XIX Dental Program. The University of Iowa Public Policy Center, 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/27\">",
"      Wolfe JD, Weber-Gasparoni K, Kanellis MJ, Qian F. Survey of Iowa general dentists regarding the age 1 dental visit. Pediatr Dent 2006; 28:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/28\">",
"      Erickson PR, Thomas HF. A survey of the American Academy of Pediatric Dentistry membership: infant oral health care. Pediatr Dent 1997; 19:17.",
"     </a>",
"    </li>",
"    <li>",
"     Unpublished data. Task Force on Residency Standards. Practitioners Survey. American Academy of Pediatric Dentistry, Chicago 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/30\">",
"      Bubna S, Perez-Spiess S, Cernigliaro J, Julliard K. Infant oral health care: beliefs and practices of american academy of pediatric dentistry members. Pediatr Dent 2012; 34:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/31\">",
"      American Academy of Pediatrics Ad Hoc Task Force on Definition of the Medical Home: The medical home. Pediatrics 1992; 90:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/32\">",
"      Medical Home Initiatives for Children With Special Needs Project Advisory Committee. American Academy of Pediatrics. The medical home. Pediatrics 2002; 110:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/33\">",
"      Nowak AJ, Casamassimo PS. The dental home: a primary care oral health concept. J Am Dent Assoc 2002; 133:93.",
"     </a>",
"    </li>",
"    <li>",
"     Nowak A. The Dental Home. In: Pediatric Dentistry - Infancy Through Adolescence, 3rd ed, Pinkham J, Casamassimo P, Fields H, et al (Eds), WB Saunders, Philadelphia 1999. p.198.",
"    </li>",
"    <li>",
"     Augustyn M, Frank DA, Zuckerman BS. Infancy and toddler years. In: Developmental-Behavioral Pediatrics, 4th, Carey WB, Crocker AC, Coleman WL, et al (Eds), Saunders Elsevier, Philadelphia 2009. p.24.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/36\">",
"      BRAZELTON TB. Crying in infancy. Pediatrics 1962; 29:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/37\">",
"      Ravn JJ. The prevalence of dummy and finger sucking habits in Copenhagen children until the age of 3 years. Comm Dent Oral Epidemiol 1974; 2:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/38\">",
"      K&ouml;hler L, Holst K. Malocclusion and sucking habits of four-year-old children. Acta Paediatr Scand 1973; 62:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/39\">",
"      Warren JJ, Bishara SE. Duration of nutritive and nonnutritive sucking behaviors and their effects on the dental arches in the primary dentition. Am J Orthod Dentofacial Orthop 2002; 121:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/40\">",
"      Friman PC, Schmitt BD. Thumb sucking: pediatricians' guidelines. Clin Pediatr (Phila) 1989; 28:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/41\">",
"      Wake M, Hesketh K, Allen M. Parent beliefs about infant teething: a survey of Australian parents. J Paediatr Child Health 1999; 35:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/42\">",
"      King DL. Teething revisited. Pediatr Dent 1994; 16:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/43\">",
"      Wake M, Hesketh K, Lucas J. Teething and tooth eruption in infants: A cohort study. Pediatrics 2000; 106:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/44\">",
"      Wake M, Hesketh K. Teething symptoms: cross sectional survey of five groups of child health professionals. BMJ 2002; 325:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/45\">",
"      Macknin ML, Piedmonte M, Jacobs J, Skibinski C. Symptoms associated with infant teething: a prospective study. Pediatrics 2000; 105:747.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Consumer Updates. Benzocaine and Babies: Not a Good Mix. Available at: www.fda.gov/ForConsumers/ConsumerUpdates/ucm306062.htm (Accessed on August 03, 2012).",
"    </li>",
"    <li>",
"     Questions &amp; Answers: Reports of a rare, but serious and potentially fatal adverse effect with the use of over-the-counter (OTC) benzocaine gels and liquids applied to the gums or mouth www.fda.gov/Drugs/DrugSafety/ucm250029.htm (Accessed on August 03, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/48\">",
"      Erickson PR, Mazhari E. Investigation of the role of human breast milk in caries development. Pediatr Dent 1999; 21:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/49\">",
"      Erickson PR, McClintock KL, Green N, LaFleur J. Estimation of the caries-related risk associated with infant formulas. Pediatr Dent 1998; 20:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/50\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     Fomon SJ. Recommendations for feeding normal infants. In: Nutrition of Normal Infants, Mosby, St. Louis 1993. p.455.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/52\">",
"      Bishara SE, Nowak AJ, Kohout FJ, et al. Influence of feeding and non-nutritive sucking methods on the development of the dental arches: longitudinal study of the first 18 months of life. Pediatr Dent 1987; 9:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/53\">",
"      Labbok MH, Hendershot GE. Does breast-feeding protect against malocclusion? An analysis of the 1981 Child Health Supplement to the National Health Interview Survey. Am J Prev Med 1987; 3:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/54\">",
"      Legovi M, Ostri L. The effects of feeding methods on the growth of the jaws in infants. ASDC J Dent Child 1991; 58:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/55\">",
"      Meyers A, Hertzberg J. Bottle-feeding and malocclusion: is there an association? Am J Orthod Dentofacial Orthop 1988; 93:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/56\">",
"      Hong L, Levy SM, Broffitt B, et al. Timing of fluoride intake in relation to development of fluorosis on maxillary central incisors. Community Dent Oral Epidemiol 2006; 34:299.",
"     </a>",
"    </li>",
"    <li>",
"     Recommendations for using fluoride to prevent and control dental caries in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001; 50:1. Available at: www.cdc.gov/mmwr/PDF/RR/RR5014.pdf (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/58\">",
"      Rozier RG, Adair S, Graham F, et al. Evidence-based clinical recommendations on the prescription of dietary fluoride supplements for caries prevention: a report of the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2010; 141:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/59\">",
"      Lalumandier JA, Ayers LW. Fluoride and bacterial content of bottled water vs tap water. Arch Fam Med 2000; 9:246.",
"     </a>",
"    </li>",
"    <li>",
"     Fluoride content of bottled, filtered, and conditioned water. Wisconsin Department of Health and Family Services. Available at: www.dhfs.state.wi.us/Health/Oral_Health/pdf_files/pph4559.pdf (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/61\">",
"      Jobson MD, Grimm SE 3rd, Banks K, Henley G. The effects of water filtration systems on fluoride: Washington, D.C. metropolitan area. ASDC J Dent Child 2000; 67:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/62\">",
"      Ong YS, Williams B, Holt R. The effect of domestic water filters on water fluoride content. Br Dent J 1996; 181:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/63\">",
"      Robinson SN, Davies EH, Williams B. Domestic water treatment appliances and the fluoride ion. Br Dent J 1991; 171:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/64\">",
"      Groman KW, Nazif MM, Zullo T. The effects of water conditioning on fluoride concentration. ASDC J Dent Child 1980; 47:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/65\">",
"      Richards A, Likimani S, Baelum V, Fejerskov O. Fluoride concentrations in unerupted fluorotic human enamel. Caries Res 1992; 26:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/66\">",
"      Fejerskov O, Manji F, Baelum V. The nature and mechanisms of dental fluorosis in man. J Dent Res 1990; 69 Spec No:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/67\">",
"      Bawden JW, Crenshaw MA, Wright JT, LeGeros RZ. Consideration of possible biologic mechanisms of fluorosis. J Dent Res 1995; 74:1349.",
"     </a>",
"    </li>",
"    <li>",
"     DenBesten PK, Giambro NJ. Dental fluorosis. In: Dental Enamel Formation to Destruction, Robinson C, Kirkham J, Shore R (Eds), CRC Press, Boca Raton, FL 1995. p.245.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/69\">",
"      Levy SM, Broffitt B, Marshall TA, et al. Associations between fluorosis of permanent incisors and fluoride intake from infant formula, other dietary sources and dentifrice during early childhood. J Am Dent Assoc 2010; 141:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33192/abstract/70\">",
"      Berg J, Gerweck C, Hujoel PP, et al. Evidence-based clinical recommendations regarding fluoride intake from reconstituted infant formula and enamel fluorosis: a report of the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2011; 142:79.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6279 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-8C22B84DCE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33192=[""].join("\n");
var outline_f32_26_33192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24949228\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SCREENING EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DENTAL REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      First dental visit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Dental home",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ANTICIPATORY GUIDANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Nonnutritive sucking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Teething",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Oral hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Dietary habits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fluoride",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Fluorosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DENTAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24949228\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6279\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6279|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/33/42525\" title=\"figure 1\">",
"      Normal primary tooth eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6279|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/21/7505\" title=\"picture 1\">",
"      Knee-to-knee position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/41/23186\" title=\"picture 2\">",
"      Infant oral health problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/4/21583\" title=\"picture 3\">",
"      Moderate fluorosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6279|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/16/30987\" title=\"table 1\">",
"      Fluoride supplementation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/37/5725\" title=\"table 2\">",
"      Cariogenic potential beverages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/46/20203\" title=\"table 3\">",
"      Fluoride content bottled water",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/42/39590?source=related_link\">",
"      Anatomy and development of the teeth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=related_link\">",
"      Children with special health care needs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32489?source=related_link\">",
"      Evaluation and management of dental injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10938?source=related_link\">",
"      Introducing solid foods and vitamin and mineral supplementation during infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19320?source=related_link\">",
"      Oral habits and orofacial development in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30216?source=related_link\">",
"      Soft tissue lesions of the oral cavity in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_26_33193="Symptom-based management of amyotrophic lateral sclerosis";
var content_f32_26_33193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Symptom-based management of amyotrophic lateral sclerosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Nestor Galvez-Jimenez, MD, MSc, MHSA, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Ira N Targoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33193/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/26/33193/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that causes muscle weakness, disability, and eventually death, with a median survival of three to five years. Symptomatic management is the mainstay of treatment for ALS, and is reviewed in this topic. Other aspects of ALS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40280?source=see_link\">",
"     \"Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16938?source=see_link\">",
"     \"Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23240?source=see_link\">",
"     \"Disease modifying treatment of amyotrophic lateral sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;ALS is a progressive neurodegenerative disorder. Most ALS patients die within three to five years of diagnosis. However, longer survival is not rare. About 30 percent of ALS patients are alive five years after diagnosis, and 10 to 20 percent survive for greater than 10 years. Long-term survival is associated with a younger age at symptom onset, male gender, and limb rather than bulbar symptom onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BREAKING THE NEWS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Informing the patient and family of the diagnosis of ALS is a daunting task for the clinician. The diagnosis should always be given face-to-face, with enough time to ensure no rushing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. It may be helpful to have the patient's support network present; European guidelines note a perceived advantage if the patient&rsquo;s network outnumbers the medical staff present at the meeting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"     5",
"    </a>",
"    ]. It is important to give a warning that bad news is coming and to acknowledge and explore the patient's reaction. Allow for questions, give reassurance that the complications of ALS are treatable, and give reassurance that the patient will not be abandoned. Offer a second opinion if the patient wishes. It is often useful to schedule a return visit within a short time frame so that questions can be addressed and family members can attend if desired.",
"   </p>",
"   <p>",
"    Many patients have a delay in diagnosis that is very distressing. For these patients, a diagnosis may be good news, in that uncertainty is reduced, and active therapy can be initiated. The discussion of diagnosis should always be accompanied by a discussion of the ways that symptoms can be treated, as well as by institution of disease modifying treatment, assuming cost is not prohibitive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23240?source=see_link&amp;anchor=H2#H2\">",
"     \"Disease modifying treatment of amyotrophic lateral sclerosis\", section on 'Riluzole'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MULTIDISCIPLINARY CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multidisciplinary ALS clinics provide care from neurologists, physical therapists, occupational therapists, speech therapists, respiratory therapists, dietitians, social workers, and nursing care managers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Thus, specialized clinics can guide the management of the complex issues related to ALS, which include respiratory symptoms, nutrition, dysarthria, dysphagia, functional decline, and psychosocial problems.",
"   </p>",
"   <p>",
"    Although data are limited, some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/11\">",
"     11",
"    </a>",
"    ] studies suggest that patients with ALS who are followed by multidisciplinary or tertiary ALS centers have improved survival compared with those who are followed by general neurology clinics. In addition, multidisciplinary care may improve quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current American guidelines state that specialized multidisciplinary clinic referral should be considered for patients with ALS, with the goals of optimizing health care delivery, prolonging survival, and enhancing quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. Similarly, European guidelines note that multidisciplinary care should be available for all people affected by ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Information for healthcare practitioners and patients regarding ALS management is available from the ALS Association (",
"    <a class=\"external\" href=\"file://www.alsa.org/\">",
"     www.alsa.org",
"    </a>",
"    ) and the Muscular Dystrophy Association (",
"    <a class=\"external\" href=\"file://www.als-mda.org\">",
"     www.als-mda.org",
"    </a>",
"    ). Both organizations certify clinics that have met a variety of quality and access criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RESPIRATORY MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our suggested management of respiratory symptoms in patients with ALS is based upon the available published data, consensus guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4,5,12\">",
"     4,5,12",
"    </a>",
"    ], and clinical experience. Important aspects of pulmonary care include counseling the patient and family about potential treatments, the use of pulmonary tests to assess respiratory function, and the utility of noninvasive and invasive ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/13\">",
"     13",
"    </a>",
"    ]. The general aspects of respiratory management in patients with neuromuscular disease are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/20/35142?source=see_link\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3528?source=see_link\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the time of initial diagnosis, discussion should focus on limited aspects of diagnosis and potential treatments. A discussion of respiratory options may be deferred at this visit if the patient has no respiratory symptoms and has a vital capacity &gt;60 percent of predicted for age and height. However, respiratory management should be a topic of careful discussion very early in the course of a clinician's relationship with the patient.",
"   </p>",
"   <p>",
"    Once beyond initial diagnosis, but before respiratory symptoms occur, it is crucial to inform patients both of the respiratory choices available to them and the need for their participation in the decision-making process. Decisions about late issues, such as the desire for tracheostomy and chronic ventilatory support, must be considered as part of a patient's overall care plan. While active respiratory management should be initiated at an earlier stage, early discussion about these issues is not sufficient, as patient's views are likely to change over time.",
"   </p>",
"   <p>",
"    At all stages of the disease, patients have the right to refuse or withdraw any treatment, including mechanical ventilation. When withdrawing ventilation, opiates and anxiolytics should be used in adequate doses to relieve dyspnea and anxiety.",
"   </p>",
"   <p>",
"    It is important to offer the patient information about the terminal stage of ALS, once dyspnea or nocturnal hypoventilation begins or when the VC drops below 50 percent. Patients may fear \"choking to death,\" and describing the terminal hypercapnic coma and resulting peaceful death can provide relief from this fear in most patients and families [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulmonary tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ALS should have serial assessment of respiratory function every three months starting at the time of diagnosis. Understanding of the pace of an individual's disease is very helpful for planning appropriate interventions at the right time.",
"   </p>",
"   <p>",
"    A decrease of vital capacity (VC) to 50 percent of predicted is often associated with respiratory symptoms, and a VC of &lt;25 to 30 percent of predicted is associated with significant risk of respiratory failure or sudden death. Hypoxia and hypercarbia are late findings and thus should",
"    <strong>",
"     not",
"    </strong>",
"    be relied upon as early predictors of the need for mechanical ventilation or other forms of respiratory support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/20/35142?source=see_link\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although widely used, the VC is not an ideal test of respiratory muscle strength in patients with ALS, in part because the shape of the lung pressure-volume curve makes the VC insensitive to modest changes in muscle strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, patients with ALS and bulbar weakness may not have enough strength to make a complete seal around the mouthpiece, particularly in later stages of disease progression. This potentially limits the clinical utility of the VC at a time when prognostic information is most urgently needed regarding initiation of noninvasive ventilation. The same limitation applies to one alternative test, the maximal inspiratory pressure (MIP, also called the maximal mouth inspiratory force).",
"   </p>",
"   <p>",
"    Another alternative, the maximal sniff nasal inspiratory force (SNIF, also called the sniff nasal pressure), avoids the need for a mouthpiece and thus may be better suited than the VC and MIP for testing patients with bulbar weakness. In addition, the SNIF has been shown to correlate well with diaphragm strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/18\">",
"     18",
"    </a>",
"    ], and it is sensitive to changes in respiratory muscle strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective observational study of 98 patients with ALS, a higher proportion of patients could still perform the SNIF at the last clinic visit (before death or study completion) compared with the VC or MIP (94 versus 84 versus 79 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/20\">",
"     20",
"    </a>",
"    ]. In this study, a SNIF of &lt;40 cm H2O had a higher sensitivity for predicting six-month mortality compared with a VC of &lt;50 percent maximum (97 versus 58 percent), but a slightly lower specificity (79 versus 96 percent).",
"   </p>",
"   <p>",
"    These results support the impression that the SNIF test is clinically useful for monitoring respiratory muscle strength in patients with ALS. However, the prognostic value of the SNIF requires confirmation in larger clinical studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Noninvasive positive pressure ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninvasive positive pressure ventilation (NPPV) is a therapeutic option for many patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. It is especially useful if patients have symptoms of respiratory compromise at night, but patients often use it during waking hours as the disease progresses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3528?source=see_link&amp;anchor=H3#H3\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Management\", section on 'Noninvasive positive pressure ventilation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NIPPV improves the quality of life in patients who can tolerate its use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. It is likely, though not conclusively demonstrated, that its use prolongs life as well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ], particularly in those compliant with &ge;4 hours of NPPV each day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/22\">",
"     22",
"    </a>",
"    ] and those without severe bulbar dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/22-24\">",
"     22-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these data, we suggest the use of NPPV for patients with ALS and respiratory compromise. Similarly, current guidelines state that NPPV should be considered to treat respiratory insufficiency in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ]. Criteria for initiating noninvasive ventilation include vital capacity &lt;50 percent of predicted, or the presence of orthopnea, or sniff nasal inspiratory force &lt;40 cm, or maximal inspiratory pressure &lt;-60 cm, or abnormal nocturnal oximetry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no data-driven standards for deciding when to initiate noninvasive mechanical ventilation, but the criteria discussed above are most commonly employed at ALS centers and are recommended by current guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ]. As adjustment to NPPV requires time and patience on the part of respiratory therapists and patients, it should be initiated as early as possible in patients with respiratory compromise.",
"   </p>",
"   <p>",
"    Patient tolerance of the face mask used is crucial to the success of NPPV. There are many face masks to choose from [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/13\">",
"     13",
"    </a>",
"    ], and patients must be encouraged not to forgo treatment if they are not comfortable with the initial interface. Occasionally, small doses of anxiolytic medications will help with the adjustment as well.",
"   </p>",
"   <p>",
"    The use of NPPV is not a substitute for permanent assisted ventilation, and careful decision making regarding desire for tracheostomy and permanent ventilation must be ongoing, whether or not NPPV is employed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Invasive ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When long-term survival is the goal, invasive ventilation should be offered. The patient and family should be fully informed of the burdens and benefits of this option. For most patients, the demands of invasive ventilation are difficult or impossible to manage at home, and nursing home placement results. Fewer than 10 percent of patients with ALS choose invasive ventilation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3528?source=see_link&amp;anchor=H7#H7\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Management\", section on 'Invasive mechanical ventilation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Immunizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current infectious disease guidelines recommend annual seasonal influenza vaccination for individuals with neurologic conditions that can potentially compromise the handling of respiratory secretions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=see_link\">",
"     \"Seasonal influenza vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the pneumococcal vaccine is recommended for all individuals with chronic pulmonary conditions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therefore, patients with ALS should be treated with pneumococcal vaccination and annual seasonal influenza vaccination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DYSPHAGIA AND NUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysphagia increases the risk for insufficient caloric and fluid intake and worsening of weakness and fatigue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. It also increases the risk for aspiration and choking.",
"   </p>",
"   <p>",
"    Initial management of dysphagia includes modification of food and fluid consistency.",
"   </p>",
"   <p>",
"    In patients with ALS, limited data suggest that percutaneous gastrostomy tube (PEG) placement is associated with prolonged survival, although the degree of survival advantage is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12,25,26\">",
"     12,25,26",
"    </a>",
"    ]. In addition, nutritional supplementation using PEG may be helpful for stabilizing weight loss common in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/27\">",
"     27",
"    </a>",
"    ]. There is little or no evidence regarding the impact of PEG on quality of life in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these data, we suggest PEG placement for willing patients with ALS who have symptomatic dysphagia, and for those who develop significant weight loss even in the absence of dysphagia. PEG placement should first be discussed with the patient and family members. It is best to enlist a gastroenterologist early in the treatment when potential decisions about long-term feeding and hydration are entertained.",
"   </p>",
"   <p>",
"    For optimal safety and efficacy, PEG should be placed before the vital capacity falls to 50 percent of predicted and not in the preterminal phase, even if symptomatic dysphagia is not present at that time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"     12",
"    </a>",
"    ]. This recommendation is based on the increased morbidity of the procedure as respiratory function declines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SYMPTOM MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among the prominent symptoms of ALS addressed by national guidelines are dyspnea, muscle spasm, spasticity, sialorrhea, and pseudobulbar affect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4-6,28\">",
"     4-6,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Equally important and potentially debilitating are other problems associated with ALS. These include dysarthria, muscle weakness, functional decline, loss of ambulation, pain, sleep problems, and psychosocial issues such as depression. These issues have not been addressed by randomized controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4,6,12\">",
"     4,6,12",
"    </a>",
"    ]. Where no guideline recommendations are available, the suggestions listed here are largely based upon clinical experience and other expert reviews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/8,14,15\">",
"     8,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dysarthria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The progression of muscle weakness may make speech increasingly difficult and ultimately impossible. Speech therapy is rarely helpful; however, communication disorders specialists are important resources to help with choosing appropriate alternative communication methods. These methods may include writing with pen and paper or alphabet boards. Electronic communication devices have been extensively developed in recent years, and they can be adapted for use with either hand or eye controls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Dyspnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Providing adequate relief for dyspnea and anxiety are paramount, as these are two of the most prevalent and unpleasant symptoms in the terminal phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4\">",
"     4",
"    </a>",
"    ]. However, there are no controlled studies evaluating the treatment of dyspnea in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. The suggested approach is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify and treat reversible causes of dyspnea such as bronchospasm and pneumonia.",
"     </li>",
"     <li>",
"      Trunk elevation, chest physiotherapy, and reassurance may be helpful.",
"     </li>",
"     <li>",
"      For intermittent dyspnea, inhaled opiates such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      5 mg may be helpful. If intermittent dyspnea is severe, intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      can be given slowly up to 5 to 10 mg. For anxiety,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      0.5 to 2 mg sublingual can be useful.",
"     </li>",
"     <li>",
"      For constant dyspnea, suggested treatments include the use of opiates, eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      2.5 mg (intravenously, or subcutaneously, or transdermally, or oral equivalent) every four hours. Continuous intravenous morphine can be used for severe dyspnea.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       Diazepam",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      , 2.5 to 5 mg may be useful for nocturnal symptom control. For terminal restlessness,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"       chlorpromazine",
"      </a>",
"      25 mg PR or 12.5 mg IV every 4 to 12 hours may be used. These treatments are most appropriate for patients with endstage disease.",
"     </li>",
"     <li>",
"      For treatment of hypoxia, oxygen alone is sufficient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;No controlled studies have addressed the pharmacologic treatment of fatigue in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. Fatigue is occasionally associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/31/22004?source=see_link\">",
"     riluzole",
"    </a>",
"    treatment, but more commonly is a manifestation of the effort required to perform daily activities. For debilitating fatigue,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    is sometimes helpful. Withdrawal of riluzole may be considered in patients with debilitating fatigue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23240?source=see_link&amp;anchor=H2#H2\">",
"     \"Disease modifying treatment of amyotrophic lateral sclerosis\", section on 'Riluzole'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Muscle spasms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle spasms or cramps can cause severe pain and discomfort.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/46/15080?source=see_link\">",
"     Quinine",
"    </a>",
"    sulfate 325 mg twice a day was considered the most effective treatment option for muscle cramps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"     14",
"    </a>",
"    ]. However, the Food and Drug Administration restricted the use quinine sulfate in the United States to the treatment of malaria falciparum because of concerns regarding severe adverse events, including cardiac arrhythmias, thrombocytopenia, and severe hypersensitivity reactions, as well as potentially serious drug interactions associated with quinine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In lieu of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/46/15080?source=see_link\">",
"     quinine",
"    </a>",
"    , suggested treatment options for muscle spasms or cramps include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/52/43847?source=see_link\">",
"     levetiracetam",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/30\">",
"     30",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"     5",
"    </a>",
"    ]. Other medications tried for cramps include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/35/12855?source=see_link\">",
"     tizanidine",
"    </a>",
"    , but their utility is quite limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Spasticity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spastic muscle tone may be useful to help patients maintain antigravity power as muscle weakness progresses. However, excess spasticity can be uncomfortable and contribute to incoordination of movement.",
"   </p>",
"   <p>",
"    There are few data regarding use of pharmacologic measures for spasticity in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. A systematic review found no high quality randomized controlled trials evaluating treatments for spasticity in",
"    <span class=\"nowrap\">",
"     ALS/motor",
"    </span>",
"    neuron disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/31\">",
"     31",
"    </a>",
"    ]. Nevertheless, the available studies suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/35/12855?source=see_link\">",
"     tizanidine",
"    </a>",
"    are roughly equivalent in efficacy and have similar rates of adverse events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/32\">",
"     32",
"    </a>",
"    ]. Tizanidine is more often associated with dry mouth, while baclofen is more often associated with motor weakness.",
"   </p>",
"   <p>",
"    Thus, suggested management options for spasticity are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/31/36342?source=see_link\">",
"       Baclofen",
"      </a>",
"      starting at 5 to 10 mg twice daily to three times daily; doses up to 120 mg per day may be needed. Except in patients with a primary lateral sclerosis phenotype, a baclofen pump is usually not considered.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/35/12855?source=see_link\">",
"       Tizanidine",
"      </a>",
"      2 to 4 mg by mouth twice daily up to a total dose of 24 mg daily.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Muscle weakness and functional decline",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive muscle weakness and functional decline are hallmarks of ALS. Efforts must be made to help patients compensate for this nearly inevitable progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assistive devices such as canes, ankle foot orthoses, crutches, and walking frames can be helpful early in the course of the disease. Most patients will eventually require a wheelchair.",
"     </li>",
"     <li>",
"      Higher toilet seats and bathtub lifts help to maintain toileting and bathing independence.",
"     </li>",
"     <li>",
"      Removable headrests can help with the loss of head control that occurs with neck muscle weakness.",
"     </li>",
"     <li>",
"      Specialized eating utensils, grips, and holders can be useful.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690158188\">",
"    <span class=\"h2\">",
"     Sialorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drooling is a common symptom in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"     6",
"    </a>",
"    ]. It is caused by the combination of facial muscle weakness and reduced swallowing ability (pseudohypersalivation). The clinician must distinguish between sialorrhea and thick mucus production because treatment of these symptoms differs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Thick mucus'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Sialorrhea can be treated with the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"       Atropine",
"      </a>",
"      0.4 mg every four to six hours",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/9/29846?source=see_link\">",
"       Hyoscyamine",
"      </a>",
"      is available in several formulations, including sustained release (0.375 to 0.75 mg every 12 hours; maximum 1.5 mg per 24 hours), fast acting oral (0.125 to 0.25 mg every four hours or as needed before meals or food; maximum 1.5 mg per 24 hours), and transdermal (one or two patches every three days)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       Amitriptyline",
"      </a>",
"      10 to 150 mg once daily at bed time",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/20/11591?source=see_link\">",
"       Glycopyrrolate",
"      </a>",
"      1 mg three times daily",
"     </li>",
"     <li>",
"      Botulinum toxin injection into the salivary glands appears to be safe and useful for treating sialorrhea in patients with ALS, as demonstrated in preliminary studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/33-36\">",
"       33-36",
"      </a>",
"      ] and in a small randomized controlled trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. However, botulinum toxin injection should be used cautiously, as it has been associated with prolonged dysphagia in patients who have Machado-Joseph disease with bulbar involvement, dystonia, and parkinsonism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29242?source=see_link&amp;anchor=H7#H7\">",
"       \"The spinocerebellar ataxias\", section on 'SCA3 (Machado-Joseph disease)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low dose radiation therapy to the salivary glands is suggested if sialorrhea does not improve with pharmacologic therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5,6,28,40-42\">",
"       5,6,28,40-42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Thick mucus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thick mucus production associated with sialorrhea and increased oropharyngeal secretions can be treated in several ways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased fluid intake",
"     </li>",
"     <li>",
"      Mucolytic (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/1/20504?source=see_link\">",
"       acetylcysteine",
"      </a>",
"      200 to 400&nbsp;mg three times daily) if sufficient cough flow is present.",
"     </li>",
"     <li>",
"      Humidification of air",
"     </li>",
"     <li>",
"      Cough augmentation with respiratory therapy",
"     </li>",
"     <li>",
"      Cough augmentation with mechanical insufflation-exsufflation devices [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12,13,43-45\">",
"       12,13,43-45",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain in ALS can arise from muscle spasms and muscle spasticity. Reduced mobility can cause skin breakdown and musculoskeletal pain. Attentive nursing care is important, since frequent changes in position can help prevent skin breakdown and joint stiffness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/46\">",
"     46",
"    </a>",
"    ]. Additional management options include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Treatment of muscle spasticity and spasms (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Spasticity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Muscle spasms'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Nonopioid analgesics and antiinflammatory drugs",
"     </li>",
"     <li>",
"      Opioids can be used liberally when nonopioid analgesics fail",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pseudobulbar affect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudobulbar affect (also called emotional lability or emotional incontinence) is a term that describes sudden uncontrollable outbursts of laughter or tearfulness that occur in many patients with ALS as the disease progresses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/47\">",
"     47",
"    </a>",
"    ]. It is a result of bilateral corticobulbar tract degeneration. It may affect close to 50 percent of patients with ALS, and it is more prevalent in those with the bulbar form [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40280?source=see_link\">",
"     \"Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current treatment options for pseudobulbar affect include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The combination drug",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/13/26839?source=see_link\">",
"       dextromethorphan-quinidine",
"      </a>",
"      (20",
"      <span class=\"nowrap\">",
"       mg/10",
"      </span>",
"      mg); the recommended starting dose is one capsule once daily for seven days, then increase to one capsule twice daily with periodic reassessment to determine if continued use is necessary",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       Amitriptyline",
"      </a>",
"      10 to 150 mg at bedtime [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/49\">",
"       49",
"      </a>",
"      ]; the starting dose is 10 to 25 mg at bedtime, and dosing is increased slowly as needed",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/50/29481?source=see_link\">",
"       Fluvoxamine",
"      </a>",
"      100 to 200 mg daily [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/50\">",
"       50",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neither",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    nor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    have been shown to be effective in controlled studies, and most patients do not notice significant improvement with these agents. In contrast, a controlled trial of 140 subjects with ALS found that twice daily treatment with AVP-923, a combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    (30",
"    <span class=\"nowrap\">",
"     mg/30",
"    </span>",
"    mg), was effective for reducing the frequency and severity of pathologic laughter and crying compared with either drug alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/51\">",
"     51",
"    </a>",
"    ]. Treatment with AVP-923 was also associated with an improvement in quality of life. Adverse events with AVP-923 were described as mostly mild or moderate and included nausea, dizziness, and gastrointestinal complaints. Additional side effects such as muscle cramps, muscle spasms, and weakness appeared to be related to ALS. However, treatment-related discontinuation of AVP-923 during the four-week duration of the trial was 24 percent, compared with 6 percent for dextromethorphan and 8 percent for quinidine. A later trial found that two formulations using low-dose quinidine in the combination drug",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/13/26839?source=see_link\">",
"     dextromethorphan-quinidine",
"    </a>",
"    (30",
"    <span class=\"nowrap\">",
"     mg/10",
"    </span>",
"    mg or 20",
"    <span class=\"nowrap\">",
"     mg/10",
"    </span>",
"    mg) were both superior to placebo and were associated with lower discontinuation rates than observed for the higher-dose formulation evaluated in the earlier trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/52\">",
"     52",
"    </a>",
"    ]. The formulation of dextromethorphan-quinidine (20",
"    <span class=\"nowrap\">",
"     mg/10",
"    </span>",
"    mg) approved for marketing in the United States and Canada differs from that of AVP-923",
"    <span class=\"nowrap\">",
"     (30/30",
"    </span>",
"    mg).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    is a weak NMDA receptor antagonist, and it is proposed to act as an agonist at the sigma 1 receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. However, its mechanism of action for treating pseudobulbar palsy is unknown. The rationale for using the combination medication is that dextromethorphan is rapidly metabolized in about 90 percent of the Caucasian population by the cytochrome P450 2D6 enzyme (CYP2D6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/55,56\">",
"     55,56",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    is a selective CYP2D6 inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/57\">",
"     57",
"    </a>",
"    ]. Thus, the coadministration of quinidine reduces the metabolism and maintains serum plasma levels of dextromethorphan.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Psychosocial aspects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quality of life in patients with ALS appears to be more dependent on psychological and existential factors than physical factors such as strength or physical function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Fatigue, depression, and hopelessness are thought to be common in patients with ALS. However, the data are limited and inconsistent. As examples, a questionnaire study of 25 patients with ALS found that about 44 percent reported depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/60\">",
"     60",
"    </a>",
"    ]. In contrast, a subsequent report using semistructured interviews of 80 patients with ALS and their family caregivers found that rates of major and minor depression were relatively low (9 and 10 percent, respectively) and did not increase with disease progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/61\">",
"     61",
"    </a>",
"    ]. Nonetheless, the combined rate of 19 percent was higher than the 2 to 9 percent prevalence rate reported for depression in the general population. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=see_link&amp;anchor=H2#H2\">",
"     \"Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of depression does not appear to be associated with a desire to hasten dying in patients with end-stage ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observational data suggest that treatment of depression can improve quality of life in ALS, even in physically debilitated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/63\">",
"     63",
"    </a>",
"    ]. However, there are no controlled trials evaluating the treatment of depression in ALS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It may be useful to try a tricyclic antidepressant such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    , since it also treats other symptoms of ALS such as drooling, pseudobulbar affect, and insomnia. Selective serotonin reuptake inhibitors may also be used, particularly if side effects of tricyclics are poorly tolerated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Sleep problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep difficulty is often secondary to other problems associated with ALS. These include anxiety, depression, dysphagia, and dyspnea; inability to change posture during sleep because of weakness, muscle cramps, and fasciculations contributes to this as well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first step is to identify and treat underlying causes.",
"     </li>",
"     <li>",
"      Nocturnal oximetry or polysomnography can identify patients with oxygen desaturation who might benefit from noninvasive intermittent ventilation or noninvasive positive pressure ventilation.",
"     </li>",
"     <li>",
"      Sedatives should be used sparingly. While there are no trials evaluating the treatment of insomnia in ALS, suggested choices at bed time include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/48/13064?source=see_link\">",
"       zolpidem",
"      </a>",
"      5 to 10 mg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      10 to 150 mg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/41/32408?source=see_link\">",
"       mirtazapine",
"      </a>",
"      15 to 45 mg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/26/5542?source=see_link\">",
"       chloral hydrate",
"      </a>",
"      250 to 500 mg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      50 to 100 mg, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/3/27703?source=see_link\">",
"       flurazepam",
"      </a>",
"      15 to 30 mg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13290?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment of insomnia\", section on 'Medications'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PALLIATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;As ALS progresses, the goal of patient care changes from maximizing function to providing palliative care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4\">",
"     4",
"    </a>",
"    ]. Early hospice involvement and close interactions between hospice nurses and attending physicians are vital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hospice care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to hospice care is advised in the terminal phase of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4,8,14\">",
"     4,8,14",
"    </a>",
"    ]. A discussion of advance directives should be initiated well in advance of the terminal phase and revisited at least every six months. The clinician should play an active role in helping patients and family members find resources in the community, and the clinician should also encourage the enlistment of a social worker.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/35/21041?source=see_link\">",
"       \"Patient information: Amyotrophic lateral sclerosis (ALS) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with ALS die within three to five years of diagnosis. However, longer survival is not rare. Patients who receive multidisciplinary care at specialized ALS clinics appear to have improved survival compared with those who are followed by general neurology clinics. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Multidisciplinary care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Before respiratory symptoms occur in ALS, it is crucial to inform patients both of the available respiratory management choices and the need for their participation in the decision-making process. At all stages of the disease, patients have the right to refuse or withdraw any treatment. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For all patients with ALS, we suggest serial assessment of pulmonary function every three months starting at the time of diagnosis. Useful measures include the vital capacity (VC), maximal inspiratory pressure (MIP), and maximal sniff nasal inspiratory force (SNIF). The SNIF avoids the need for a mouthpiece and thus may be better suited than the VC or MIP for testing patients with bulbar weakness. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pulmonary tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with ALS and respiratory compromise, we suggest the use of noninvasive positive pressure ventilation (NPPV) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Suggested criteria for when to initiate NPPV are as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      VC &lt;50 percent of predicted, or",
"     </li>",
"     <li>",
"      Presence of orthopnea, or",
"     </li>",
"     <li>",
"      SNIF &lt;40 cm, or",
"     </li>",
"     <li>",
"      MIP &lt;-60 cm, or",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abnormal nocturnal oximetry (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Noninvasive positive pressure ventilation'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      When long-term survival is the goal, invasive ventilation is an option. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Invasive ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with ALS should be treated with pneumococcal vaccination and annual seasonal influenza vaccination. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Immunizations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For willing patients with ALS who have symptomatic dysphagia, we suggest PEG placement (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In addition, we suggest PEG for those who develop significant weight loss even in the absence of dysphagia (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For optimal safety, PEG should be placed before the vital capacity falls to &le;50 percent of predicted. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dysphagia and nutrition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional prominent symptoms of ALS may benefit from specific interventions. These include (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Symptom management'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dysarthria",
"     </li>",
"     <li>",
"      Dyspnea",
"     </li>",
"     <li>",
"      Muscle spasms",
"     </li>",
"     <li>",
"      Muscle spasticity",
"     </li>",
"     <li>",
"      Muscle weakness and functional decline",
"     </li>",
"     <li>",
"      Sialorrhea",
"     </li>",
"     <li>",
"      Thick mucus",
"     </li>",
"     <li>",
"      Pain",
"     </li>",
"     <li>",
"      Pseudobulbar affect",
"     </li>",
"     <li>",
"      Psychosocial aspects",
"     </li>",
"     <li>",
"      Sleep problems",
"      <br/>",
"      <br/>",
"      However, there are few controlled trials evaluating these issues in patients with ALS. Thus, most recommendations are based upon clinical experience and expert consensus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As ALS progresses, the goal of patient care changes from maximizing function to providing palliative care. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Palliative care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/1\">",
"      Eisen A, Schulzer M, MacNeil M, et al. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993; 16:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/2\">",
"      Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989; 12:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/3\">",
"      Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Can J Neurol Sci 1991; 18:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/4\">",
"      Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/5\">",
"      EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 2012; 19:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/6\">",
"      Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/7\">",
"      Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005; 65:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/8\">",
"      Mitsumoto H, Rabkin JG. Palliative care for patients with amyotrophic lateral sclerosis: \"prepare for the worst and hope for the best\". JAMA 2007; 298:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/9\">",
"      Chi&ograve; A, Bottacchi E, Buffa C, et al. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006; 77:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/10\">",
"      Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003; 74:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/11\">",
"      Zoccolella S, Beghi E, Palagano G, et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J Neurol 2007; 254:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/12\">",
"      Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/13\">",
"      Gruis KL, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: a primer. Muscle Nerve 2012; 46:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/14\">",
"      Borasio GD, Voltz R, Miller RG. Palliative care in amyotrophic lateral sclerosis. Neurol Clin 2001; 19:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/15\">",
"      Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol 2001; 21:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/16\">",
"      Rabinstein AA, Wijdicks EF. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol 2003; 23:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/17\">",
"      Fitting JW, Paillex R, Hirt L, et al. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 1999; 46:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/18\">",
"      Lyall RA, Donaldson N, Polkey MI, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124:2000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/19\">",
"      Stefanutti D, Benoist MR, Scheinmann P, et al. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 2000; 162:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/20\">",
"      Morgan RK, McNally S, Alexander M, et al. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/21\">",
"      Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006; 66:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/22\">",
"      Lo Coco D, Marchese S, Pesco MC, et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006; 67:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/23\">",
"      Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006; 5:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/24\">",
"      Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2013; 3:CD004427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/25\">",
"      Chi&ograve; A, Finocchiaro E, Meineri P, et al. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 1999; 53:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/26\">",
"      Mazzini L, Corr&agrave; T, Zaccala M, et al. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/27\">",
"      Kasarskis EJ, Scarlata D, Hill R, et al. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999; 169:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/28\">",
"      Andersen PM, Borasio GD, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007; 8:195.",
"     </a>",
"    </li>",
"    <li>",
"     FDA advances effort against marketed unapproved drugs. FDA orders unapproved quinine drugs from the market and cautions consumers about \"off-label\" use of quinine to treat leg cramps. U. S. Food and Drug Administration www.fda.gov/bbs/topics/NEWS/2006/NEW01521.html (Accessed on March 23, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/30\">",
"      Bedlack RS, Pastula DM, Hawes J, Heydt D. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler 2009; 10:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/31\">",
"      Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012; 2:CD004156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/32\">",
"      Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004; 28:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/33\">",
"      Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000; 69:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/34\">",
"      Lipp A, Trottenberg T, Schink T, et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003; 61:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/35\">",
"      Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 2006; 34:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/36\">",
"      Stone CA, O'Leary N. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis. J Pain Symptom Manage 2009; 37:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/37\">",
"      Jackson CE, Gronseth G, Rosenfeld J, et al. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve 2009; 39:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/38\">",
"      Young CA, Ellis C, Johnson J, et al. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Syst Rev 2011; :CD006981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/39\">",
"      Tuite PJ, Lang AE. Severe and prolonged dysphagia complicating botulinum toxin A injections for dystonia in Machado-Joseph disease. Neurology 1996; 46:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/40\">",
"      Harriman M, Morrison M, Hay J, et al. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis. J Otolaryngol 2001; 30:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/41\">",
"      Andersen PM, Gr&ouml;nberg H, Franzen L, Funeg&aring;rd U. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J Neurol Sci 2001; 191:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/42\">",
"      Neppelberg E, Haugen DF, Thorsen L, Tysnes OB. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol 2007; 14:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/43\">",
"      Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993; 104:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/44\">",
"      Mustfa N, Aiello M, Lyall RA, et al. Cough augmentation in amyotrophic lateral sclerosis. Neurology 2003; 61:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/45\">",
"      Sancho J, Servera E, Vergara P, Mar&iacute;n J. Mechanical insufflation-exsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: a pilot study. Am J Phys Med Rehabil 2003; 82:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/46\">",
"      Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry 1985; 48:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/47\">",
"      Rosen HJ, Cummings J. A real reason for patients with pseudobulbar affect to smile. Ann Neurol 2007; 61:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/48\">",
"      Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989; 80:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/49\">",
"      Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 1985; 312:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/50\">",
"      Iannaccone S, Ferini-Strambi L. Pharmacologic treatment of emotional lability. Clin Neuropharmacol 1996; 19:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/51\">",
"      Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004; 63:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/52\">",
"      Pioro EP, Brooks BR, Cummings J, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol 2010; 68:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/53\">",
"      Klein M, Musacchio JM. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J Pharmacol Exp Ther 1989; 251:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/54\">",
"      Tortella FC, Pellicano M, Bowery NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 1989; 10:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/55\">",
"      Hildebrand M, Seifert W, Reichenberger A. Determination of dextromethorphan metabolizer phenotype in healthy volunteers. Eur J Clin Pharmacol 1989; 36:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/56\">",
"      Schadel M, Wu D, Otton SV, et al. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol 1995; 15:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/57\">",
"      Zhang Y, Britto MR, Valderhaug KL, et al. Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. Clin Pharmacol Ther 1992; 51:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/58\">",
"      Simmons Z, Bremer BA, Robbins RA, et al. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000; 55:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/59\">",
"      Goldstein LH, Atkins L, Landau S, et al. Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology 2006; 67:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/60\">",
"      Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003; 60:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/61\">",
"      Rabkin JG, Albert SM, Del Bene ML, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005; 65:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/62\">",
"      Albert SM, Rabkin JG, Del Bene ML, et al. Wish to die in end-stage ALS. Neurology 2005; 65:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33193/abstract/63\">",
"      McDonald ER, Wiedenfeld SA, Hillel A, et al. Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol 1994; 51:17.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5129 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-C2D6B77659-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33193=[""].join("\n");
var outline_f32_26_33193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BREAKING THE NEWS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MULTIDISCIPLINARY CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RESPIRATORY MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulmonary tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Noninvasive positive pressure ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Invasive ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Immunizations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DYSPHAGIA AND NUTRITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SYMPTOM MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dysarthria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Dyspnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Muscle spasms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Spasticity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Muscle weakness and functional decline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690158188\">",
"      Sialorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Thick mucus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pseudobulbar affect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Psychosocial aspects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Sleep problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PALLIATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hospice care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40280?source=related_link\">",
"      Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16938?source=related_link\">",
"      Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23240?source=related_link\">",
"      Disease modifying treatment of amyotrophic lateral sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/35/21041?source=related_link\">",
"      Patient information: Amyotrophic lateral sclerosis (ALS) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/20/35142?source=related_link\">",
"      Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3528?source=related_link\">",
"      Respiratory muscle weakness due to neuromuscular disease: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29242?source=related_link\">",
"      The spinocerebellar ataxias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/62/13290?source=related_link\">",
"      Treatment of insomnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=related_link\">",
"      Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_26_33194="Pathology and molecular pathogenesis of gastric cancer";
var content_f32_26_33194=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathology and molecular pathogenesis of gastric cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Pelayo Correa, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/26/33194/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/26/33194/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric adenocarcinoma is one of the few malignant neoplasms for which infectious agents have been recognized as having an important etiologic role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 1994, based mostly upon epidemiologic evidence, the International Agency for Research on Cancer (IARC), a part of the World Health Organization (WHO), recognized infection by Helicobacter pylori (H. pylori) as a primary cause of gastric adenocarcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/2\">",
"       2",
"      </a>",
"      ]. Left untreated, H. pylori infection leads to life-long chronic active gastritis, which is a risk factor for both intestinal and diffuse gastric adenocarcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/3\">",
"       3",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, H. pylori-associated preneoplastic lesions are a feature of intestinal-type gastric cancer and not the diffuse-type. The diffuse type is more likely to have a primary genetic etiology, and the involvement of H. pylori is probably limited to a subset of sporadic cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/4\">",
"       4",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Outcomes of H. pylori infection vary individually, and only a small minority of infected subjects develop gastric cancer (estimated at approximately three cases per year for every 10,000 infected persons). There are approximately 1,000,000 gastric cancer cases per year and 3.25 billion people infected with H. pylori worldwide. It is thought that modulation of the effects of H. pylori by genetic susceptibility, external (mostly environmental) forces, and possibly bacterial strain differences influence its evolution into a neoplastic or nonneoplastic process. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link\">",
"       \"Association between Helicobacter pylori infection and gastrointestinal malignancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epstein&ndash;Barr virus (EBV) is detected in 2 to 16 percent of gastric adenocarcinomas worldwide; there is a higher frequency in tumors of the proximal and middle portion of the stomach [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/5-8\">",
"       5-8",
"      </a>",
"      ]. Several EBV-related genes (including EBER-1, EBER2, EBNA1, LMP2A, BARF0, and BARF1) are expressed in gastric cancers. However, in contrast to H. pylori, their role in gastric carcinogenesis is not yet established.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence of gastric cancer has been steadily declining in many countries, following a birth cohort pattern. However, this trend has been interrupted and replaced by an upward trend in young patients in recent years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/9\">",
"     9",
"    </a>",
"    ]. The causes of this phenomenon are unknown. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=see_link&amp;anchor=H91192772#H91192772\">",
"     \"Epidemiology of gastric cancer\", section on 'Incidence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Intestinal versus diffuse types",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two distinct types of gastric adenocarcinoma, intestinal (well-differentiated) and diffuse (undifferentiated), which have distinct morphologic appearance, epidemiology, pathogenesis, and genetic profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The morphologic differences are attributable to intercellular adhesion molecules, which are well preserved in intestinal-type tumors and defective in diffuse carcinomas. In intestinal tumors, the tumor cells adhere to each other, and tend to arrange themselves in tubular or glandular formations, similar to adenocarcinomas arising elsewhere in the intestinal tract (hence their designation as intestinal-type). In contrast, a lack of adhesion molecules in diffuse carcinomas allows the individual tumor cells to grow and invade neighboring structures without the formation of tubules or glands.",
"   </p>",
"   <p>",
"    A molecular basis for this difference is now apparent. The main carcinogenic event in diffuse carcinomas is loss of expression of E-cadherin, a key cell surface protein for establishing intercellular connections and maintaining the organization of epithelial tissues. Biallelic inactivation of the gene encoding E-cadherin,",
"    <em>",
"     CDH1",
"    </em>",
"    , can occur through germline or somatic mutation, allelic imbalance events (eg, loss of heterozygosity), or epigenetic silencing of gene transcription through aberrant methylation of the CDH1 promoter. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Diffuse type cancers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Gene expression studies have identified two molecularly distinct types of gastric carcinoma: intestinal (G-INT) and diffuse (G-DIF). The two subgroups correlate partially with the classical intestinal and diffuse morphologic types according to Lauren&rsquo;s histopathological classification described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the concordance between the genomic and the histopathologic classifications is only 64 percent. The genomic classification appears to be superior to the histopathological in separating the two nosologic entities in terms of prognostic stratification. Kaplan-Meier curves clearly indicate better prognosis for G-INT than G-DIF. Furthermore, molecular classification avoids the need to resort to terms such as&nbsp;&ldquo;mixed&rdquo; or &ldquo;unclassifiable&rdquo; to classify tumors histologically.&nbsp;Genomic variants also have therapeutic implications. G-INT tumor cells may be more susceptible to 5-FU and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    while G-DIF cells appear to be more susceptible to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In direct contrast, the pathogenesis of intestinal-type gastric cancers is less well defined. However, it appears to follow a multistep progression that is usually initiated by H. pylori infection.",
"   </p>",
"   <p>",
"    Some tumors display areas of both intestinal and diffuse phenotypes. In such cases,",
"    <em>",
"     CDH1",
"    </em>",
"    mutations and loss of expression of E-cadherin are seen only in the diffuse component of the tumor, suggesting that E-cadherin loss may be the genetic basis for the divergence of a diffuse-type clone from an intestinal-type gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following sections describe the histologic appearance, presence of preneoplastic lesions, and molecular pathogenesis for the intestinal and diffuse subtypes of gastric cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INTESTINAL TYPE CANCERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intestinal type of gastric adenocarcinoma is most common in high-risk populations, more likely to be sporadic than inherited, and related to environmental factors such as diet, cigarette smoking and alcohol use. It is also the type that has decreased most markedly over the past several decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In low-risk populations, the frequency of intestinal-type gastric adenocarcinomas more closely approximates the incidence of diffuse-type tumors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link\">",
"     \"Risk factors for gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     H. pylori and the preneoplastic cascade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intestinal-type tumors are causally related to H. pylori. While the infection usually starts in infancy or early childhood, there is a long latency period, and cancers are clinically diagnosed four or more decades later. During this period, a prolonged precancerous process takes place, represented by a \"cascade\" of events with the following well-characterized, sequential histopathologic stages: chronic active non-atrophic gastritis; multifocal atrophic gastritis; intestinal metaplasia (complete, then incomplete); dysplasia; and invasive carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While there is a steady progression from infection to invasive cancer, there may be temporary episodes of regression to a less advanced stage. The manner in which environmental risk factors contribute to or influence the progression of H. pylori-induced gastric carcinogenesis is unclear. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link\">",
"     \"Risk factors for gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Non-atrophic gastritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first stage, non-atrophic gastritis, predominates in the gastric antrum and is characterized by an interstitial infiltrate of lymphocytes, macrophages, and plasma cells (",
"    <a class=\"graphic graphic_picture graphicRef53009 \" href=\"mobipreview.htm?28/47/29434\">",
"     picture 1",
"    </a>",
"    ). Occasionally, lymphoid follicles are formed. The term \"activity\" has been coined to specify the presence of focal acute inflammation (infiltration of polymorphonuclear neutrophils [PMNs] in the stroma and epithelial layer) in a background of chronic gastritis. For unknown reasons, the PMNs tend to be more abundant in the gland necks, where active epithelial replication takes place. Occasionally, collections of PMNs (microabscesses) are seen in the glandular lumen. The presence of PMNs correlates closely with active colonization of the gastric lumen by H. pylori organisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Atrophic gastritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrophic gastritis is characterized by multifocal loss of the original gastric glands, including mucus secreting glands in the antrum, and parietal and chief cells in the corpus. In some patients, active gastritis does not lead to gland loss. Non-atrophic antral gastritis is the predominant finding in patients who have an H. pylori-associated duodenal peptic ulcer. Such patients do not have an increased cancer risk, when compared to the general population. This finding supports the view that atrophy (gland loss) is the first histopathologic lesion of the preneoplastic cascade (",
"    <a class=\"graphic graphic_picture graphicRef62367 \" href=\"mobipreview.htm?35/19/36153\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H9#H9\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Importance of other factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Intestinal metaplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifocal atrophy involving the gastric mucosa may be followed by the appearance of glands having an intestinal phenotype, termed intestinal metaplasia. These glands are first seen at the junction of the antrum and the corpus (ie, oxyntic) mucosa, especially in the area of the incisura angularis. The foci of metaplasia become larger and more numerous over time, extending to the antrum as well as to the corpus of the gastric mucosa. The larger the atrophic and metaplastic area, the greater the cancer risk.",
"   </p>",
"   <p>",
"    As atrophic and metaplastic glands replace original glands, the normal gastric secretions decrease, leading to hypochlorhydria and low levels of pepsinogen I (produced by the chief cells of the corpus) and gastrin 17 (produced by antral G cells). These markers can be measured in the serum and can be used as an indicator of gastric atrophy and cancer risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31205?source=see_link&amp;anchor=H4#H4\">",
"     \"Classification and diagnosis of gastritis and gastropathy\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The first metaplastic glands seen in the gastric mucosa phenotypically resemble those of the small intestine, with eosinophilic absorptive enterocytes with a brush border (multiple microvilli), alternating with mucus-producing goblet cells. This is the type I, complete, or small intestinal metaplasia (",
"    <a class=\"graphic graphic_picture graphicRef81064 \" href=\"mobipreview.htm?33/30/34277\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    More advanced stages are characterized by phenotypic changes that are more similar to colonic mucosa with the glands becoming lined by irregular goblet cells (type III, incomplete or colonic metaplasia) (",
"    <a class=\"graphic graphic_picture graphicRef77310 \" href=\"mobipreview.htm?39/7/40054\">",
"     picture 4",
"    </a>",
"    ). Colonic metaplasia is frequently found around small (early) gastric carcinomas. Some consider colonic metaplasia to represent an early stage of dysplasia, deserving closer endoscopic surveillance than type I (small intestinal) metaplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysplasia (also called intraepithelial neoplasia) is the next step in the progression of the precancerous process. Although dysplastic cells have a neoplastic phenotype (ie, they are large, hyperchromatic, and have disorganized nuclei) (",
"    <a class=\"graphic graphic_picture graphicRef79435 \" href=\"mobipreview.htm?33/54/34662\">",
"     picture 5",
"    </a>",
"    ), they are confined to the glandular structures and do not penetrate the basement membrane.",
"   </p>",
"   <p>",
"    Dysplasias are classified as low-grade or high-grade, according to the degree of nuclear and architectural atypia and disorganization. Rates of progression to invasive carcinoma from low-grade dysplasia are 0 to 23 percent, while the corresponding rates for high-grade dysplasia are 60 to 85 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H646035135\">",
"    <span class=\"h4\">",
"     Asian versus Western nomenclature",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nomenclature of advanced premalignant lesions in Japan differs considerably from that of Western countries. In the West, gastric cancer is defined by stromal invasion, while in Japan, severe nuclear and architectural abnormalities, even if confined to glandular structures, are considered sufficient to classify a lesion as a carcinoma. Japanese pathologists use the term \"adenoma\" to describe lesions that, in Western countries, would be labeled low-grade dysplasia. The Padova classification attempts to reconcile the two systems by assigning numerical categories based upon the descriptive findings (",
"    <a class=\"graphic graphic_table graphicRef58718 \" href=\"mobipreview.htm?15/24/15756\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These discrepancies are more semantic than substantial. In Western countries, close endoscopic monitoring is considered appropriate for patients with low-grade gastric dysplasia with intervention only if the lesions progress. On the other hand, the majority of clinicians (although not all) recommend surgical or endoscopic resection for patients with high-grade dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/22\">",
"     22",
"    </a>",
"    ]. This is because areas of microinvasion can be found in some patients undergoing resection for high-grade dysplasia, although the proportion is not well established. In Japan, most \"adenomas\" and \"early carcinomas\" do not undergo surveillance, but are treated with endoscopic resection, a technique that is used much less in the West. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"     \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Invasive carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Grossly, most intestinal-type carcinomas are ulcerated masses that are located in the region of the incisura angularis and its neighboring antral and corpus mucosa (",
"    <a class=\"graphic graphic_figure graphicRef79793 \" href=\"mobipreview.htm?4/45/4817\">",
"     figure 1",
"    </a>",
"    ). Some have their epicenter in the antrum or the corpus, away from the antrum-corpus junction.",
"   </p>",
"   <p>",
"    Proximal carcinomas that are located in the cardia differ in a number of ways from more distal cancers:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      From an epidemiologic standpoint, although the incidence of gastric cancer has decreased over the past several decades, this is accounted for almost exclusively by distal cancers. Cancers of the proximal stomach and GE junction have actually increased in frequency. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=see_link&amp;anchor=H5#H5\">",
"       \"Epidemiology of gastric cancer\", section on 'Change in histology pattern'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardia cancers are also biologically more aggressive, with a worse prognosis, stage for stage, than distal cancers. Cardia cancers have a greater tendency toward deeper wall penetration, lymph node metastases and lymphatic vessel invasion.",
"     </li>",
"     <li>",
"      Some have suggested that the genetic alterations seen in cardia cancers more closely resemble those of esophageal rather than distal gastric adenocarcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/23,24\">",
"       23,24",
"      </a>",
"      ], although this is not a consistent finding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The relationship of proximal gastric cancers with H. pylori infection and their association with preneoplastic atrophic",
"      <span class=\"nowrap\">",
"       gastritis/intestinal",
"      </span>",
"      metaplasia has been questioned [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/26-28\">",
"       26-28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All of these observations support the view that at least a subset of proximal cancers represent a separate subtype from distal gastric cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been proposed that the specific mucin phenotypes expressed by proximal versus distal gastric carcinomas may provide some indication as to the cell of origin and therefore, the expected biologic behavior [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/29\">",
"     29",
"    </a>",
"    ]. However, the expression of mucins during the precancerous process is variable. MUC2 (an intestinal mucin) predominates in complete metaplasia; incomplete metaplasia, which occurs later in the process, expresses also MUC5 AC (a gastric type of mucin) as well as colonic types of mucins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/30\">",
"     30",
"    </a>",
"    ]. Thus, the controversial \"cell of origin\" of gastric cancer is not identified by mucin phenotype, and as will be discussed below, may actually arise from bone marrow. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Migrating bone marrow derived cells'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H646035157\">",
"    <span class=\"h4\">",
"     Histologic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO classification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/20\">",
"     20",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef57594 \" href=\"mobipreview.htm?8/27/8637\">",
"     table 2",
"    </a>",
"    ) assigns the terms tubular, papillary and mucinous to the histologic varieties of intestinal-type cancers. Rarely, adenosquamous histology is observed. Some intestinal-type tumors do not form tubules and their cells form solid aggregates. They are known as solid tumors because the multiple cell adhesions lead to sheets of cohesive cell aggregates without polarity or gland formation.",
"   </p>",
"   <p>",
"    Regardless of the specific variant, the depth of invasion into the stomach wall determines the primary tumor (T) stage. In this regard, there are marked differences between the Western and the Japanese classifications. The Western system follows the TNM classification, as defined by the combined AJCC (American Joint Committee on",
"    <span class=\"nowrap\">",
"     Cancer)/UICC",
"    </span>",
"    (International Union Against Cancer) TNM staging system (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"mobipreview.htm?11/6/11374\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\", section on 'Staging systems'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This TNM classification is prognostically relevant, and there are significant differences in five-year survival rates for localized, regional or advanced categories (",
"    <a class=\"graphic graphic_figure graphicRef69815 \" href=\"mobipreview.htm?17/0/17409\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/15/33018?source=see_link&amp;anchor=H19#H19\">",
"     \"Invasive gastric cancer: Surgery and prognosis\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, the Japanese staging system was designed to fulfill a different role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/32\">",
"     32",
"    </a>",
"    ]. It represents a comprehensive guide to surgical treatment, linking the topographic location of the primary tumor within the stomach to the specific location of the lymphatic nodes to be resected. The TNM system classifies nodal (N) stage only according to the number of lymph nodes with metastasis, irrespective of location [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/31\">",
"     31",
"    </a>",
"    ]. The TNM system is preferred since it more accurately indicates prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/31,33,34\">",
"     31,33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Models of molecular pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is compelling evidence for the role of H. pylori in the initiation of the events that lead from chronic active gastritis to atrophic gastritis, intestinal metaplasia, dysplasia, and finally adenocarcinoma. The relationship between H. pylori infection and gastric carcinogenesis in humans can be illustrated by the following observations (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H2#H2\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Gastric cancer'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Epidemiologic studies and several meta-analyses demonstrate a strong correlation between H. pylori seropositivity and gastric cancer incidence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H. pylori can be identified histologically in the uninvolved mucosa from stomachs harboring cancers or precancerous changes such as atrophic gastritis with or without intestinal metaplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/37,38\">",
"       37,38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Regression of premalignant lesions has been demonstrated with eradication of H. pylori [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/39,40\">",
"     39,40",
"    </a>",
"    ], although whether progression to invasive gastric cancer can be halted is still unclear. Only one randomized trial was sufficiently powered to demonstrate that invasive cancer can be prevented if anti-Helicobacter treatment is undertaken before the development of gastric precancerous lesions such as atrophy or intestinal metaplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H11#H11\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Does treatment reduce risk of gastric cancer?'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several hypotheses have been proposed to explain the role of H. pylori in gastric cancer initiation, although the exact mechanism is incompletely understood. Initiation of the carcinogenesis process has been linked to oxidative stress brought about by inducible nitric oxide synthase (iNOS) that is produced by inflammatory cells responding to H. pylori infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/42\">",
"     42",
"    </a>",
"    ]. Nitric oxides are mutagenic and may induce abnormalities in the DNA of epithelial cells. iNOS has been found in the cytoplasm of dysplastic cells and gastric carcinomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/43\">",
"     43",
"    </a>",
"    ]. Furthermore, support for the role of oxidative and nitrosative stress in gastric carcinogenesis is provided by the finding that H. pylori isolates from high cancer risk populations have the ability to induce excessive expression of iNOS and spermine oxidase (SM0), enzymes linked to DNA damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ancestral origin of H. pylori strains also appears to play an important role in the rates of gastric cancer; this is likely due to the differences in the capacity of different strains to express CagA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=see_link&amp;anchor=H5#H5\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\", section on 'Bacterial strain differences'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Seven prototypes of H. pylori have been identified by multilocus sequence typing (MLST): European, North African, Western African, South African, Asian (India, Bangladesh, Thailand, Malaysia), Australian, and East Asian (with three subgroups for East Asia, Maori and Amerindian) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. H. pylori isolates from the Colombian Andes Mountains carry the European genotype, probably representing the contact between the original Amerindian strains brought thousands of years ago and the European strains brought some 500 years ago. By contrast, isolates from Pacific coastal dwellers, predominantly of African ancestry, show heterogeneous ancestry: approximately 70 percent have African genotypes, indicating that their H. pylori strains were brought from Africa and have persisted over the centuries. The other 30 percent have European genotypes, probably representing a similar phenomenon to that of the Mountain dwellers.",
"   </p>",
"   <p>",
"    Isolates of African ancestry induce less severe histopathologic lesions and express less DNA damage to the gastric mucosa than those of European ancestry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/47\">",
"     47",
"    </a>",
"    ]. These findings may at least partially explain the so called African enigma: a high prevalence of H. pylori infection, but very low gastric cancer rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/48\">",
"     48",
"    </a>",
"    ]. Isolates from the Andes mountains (with European ancestry) express higher levels of CagA protein when exposed to salt (NaCl) than isolates with African ancestry. The capacity to express CagA is linked to a specific motif (AATAAGATA), very frequent in isolates with European ancestry, but very rare in isolates with African ancestry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The subsequent molecular events that promote progression through the preneoplastic cascade and culminate in the development of an invasive gastric cancer in patients infected with H. pylori are largely unknown. The following proposed models reflect the state of the art.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Sequential accumulation of genetic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The multistage precancerous cascade described above represents a model of carcinogenesis that is similar to the adenoma-carcinoma sequence described for colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/50\">",
"     50",
"    </a>",
"    ]. The well-established \"Vogelstein\" model of colorectal carcinogenesis links progression through the",
"    <span class=\"nowrap\">",
"     adenoma/carcinoma",
"    </span>",
"    sequence with the sequential acquisition of specific molecular genetic and epigenetic alterations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link\">",
"     \"Molecular genetics of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although it is proposed that the well-defined histopathologic stages of gastric carcinogenesis are also accompanied by a stepwise accumulation of genetic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epigenetic alterations, attempts to replicate the colorectal carcinogenesis model for gastric cancer have not been successful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/17,51\">",
"     17,51",
"    </a>",
"    ]. Many gene changes have been described in various stages of the",
"    <span class=\"nowrap\">",
"     preneoplastic/neoplastic",
"    </span>",
"    cascade, but the alterations do not generally follow a sequential arrangement. Some changes are seen in early preneoplastic lesions, but not present in more advanced lesions.",
"   </p>",
"   <p>",
"    A comprehensive compilation of all of the studies investigating the molecular pathogenesis of gastric cancer is beyond the scope of this review. What follows is a brief synopsis of selected abnormalities in oncogenes, tumor suppressor genes, growth",
"    <span class=\"nowrap\">",
"     factors/receptors,",
"    </span>",
"    cell cycle regulators, as well as epigenetic alterations. Some of these have been linked to H. pylori infection, while the relationship of many to H. pylori infection remains unresolved.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oncogenes &mdash; Several oncogenes are overexpressed in various stages of gastric carcinogenesis, although none has consistently been shown to be present in any one particular stage. As examples:",
"     </li>",
"     <li>",
"      Early involvement of",
"      <em>",
"       K-ras",
"      </em>",
"      mutations is suggested by their being found in invasive cancers, dysplasia, and intestinal metaplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Involvement of the",
"      <em>",
"       c-met",
"      </em>",
"      oncogene, encoding the hepatocyte growth factor receptor, is supported by the finding that gene expression is amplified in 19 percent of intestinal-type (and 39 percent of diffuse-type) gastric cancers. Expression of the 6.0 kb c-met transcript in particular correlates well with more advanced disease stage at presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/53\">",
"       53",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In vitro, highly virulent strains of H. pylori that make the effector protein CagA appear to modulate c-met receptor signal transduction pathways, and this might influence cancer initiation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tumor progression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H6#H6\">",
"       \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'H. pylori strain differences'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tumor suppressor genes &mdash; Approximately 50 percent of intestinal-type gastric cancers have alterations in genes that are thought to function as tumor suppressor genes, including",
"      <em>",
"       TP53,",
"      </em>",
"      <em>",
"       TP73",
"      </em>",
"      ,",
"      <em>",
"       APC",
"      </em>",
"      (adenomatous polyposis coli), TFF (trefoil factor family),",
"      <em>",
"       DCC",
"      </em>",
"      (deleted in colon cancer), and",
"      <em>",
"       FHIT",
"      </em>",
"      (fragile histidine triad) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/51,55-68\">",
"       51,55-68",
"      </a>",
"      ]. As examples:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The p53 gene (",
"      <em>",
"       TP53",
"      </em>",
"      ) is an important regulator of the cell cycle, in particular at the point at which damaged cells must progress through cell-cycle arrest and repair versus apoptosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/55\">",
"       55",
"      </a>",
"      ].Loss of TP53 expression by LOH or mutational inactivation is the most frequent genetic alteration in gastric cancer, occurring in over 60 percent of invasive tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/51,63\">",
"       51,63",
"      </a>",
"      ]. Abnormalities are also found in H. pylori-associated chronic gastritis, intestinal metaplasia and dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/55,56,60,61,69\">",
"       55,56,60,61,69",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      How p53 interacts with H. pylori is uncertain. p53 appears to be a key regulatory molecule in the response to microenvironmental chronic inflammatory stress [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/70\">",
"       70",
"      </a>",
"      ]. Furthermore, at least some data suggest that inactivation of p53 in gastric epithelial cells may reduce their ability to undergo apoptosis in response to injury caused by H. pylori [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      LOH in TP73, a transcription factor related to TP53 that also functions as a tumor suppressor gene, can be detected in gastric carcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/57\">",
"       57",
"      </a>",
"      ], and loss of expression has also been reported via epigenetic mechanisms (promoter methylation) in EBV-associated gastric cancers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/59\">",
"       59",
"      </a>",
"      ]. Overexpression of p73 and the oncogenic isoform DeltaNp73 suppresses p73 transcriptional and apoptotic activity in gastroepithelial cancer cells, and increases intracellular beta-catenin levels, an effect that is inhibited in the presence of wild-type but not mutant p53 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/58\">",
"       58",
"      </a>",
"      ]. The importance of signaling pathways involving beta-catenin is discussed further below. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Beta-catenin/Wnt signaling'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Mutations in the",
"      <em>",
"       APC",
"      </em>",
"      (adenomatous polyposis coli) gene are identified in significantly more intestinal-type than diffuse-type gastric cancers (33 versus 13 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/71\">",
"       71",
"      </a>",
"      ]. These mutations are also found in H. pylori-associated dysplasia and intestinal metaplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/72\">",
"       72",
"      </a>",
"      ]. APC mutations modulate the",
"      <span class=\"nowrap\">",
"       Wnt/catenin",
"      </span>",
"      signaling pathway, as discussed below.",
"     </li>",
"     <li>",
"      The trefoil factor family (TFF) of proteins comprises a group of gastrointestinal peptides that are involved in the protection of the mucous epithelium. TFF1 is normally expressed in the gastroduodenal mucosa, and TFF1 knockout mice develop multiple gastric adenomas and carcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/73\">",
"       73",
"      </a>",
"      ]. Loss of TFF1 expression has been observed in intestinal metaplasia of the incomplete type [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/74\">",
"       74",
"      </a>",
"      ] and in gastric carcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cell cycle regulatory molecules &mdash; Cyclin E and Cyclin dependent kinase inhibitor 1B (CDKN1B,p27) are two important cell-cycle regulators that take part in the",
"      <span class=\"nowrap\">",
"       G1/S",
"      </span>",
"      transition. Cyclin E overexpression is a frequent event in gastric carcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/76,77\">",
"       76,77",
"      </a>",
"      ], and it might be an indicator for malignant transformation of dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/78\">",
"       78",
"      </a>",
"      ],",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tumor aggressiveness once an invasive cancer develops [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/77,79\">",
"       77,79",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Decreased expression of cyclin dependent kinase inhibitor 1B also correlates with an adverse prognosis in invasive gastric cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/79,80\">",
"       79,80",
"      </a>",
"      ]. Furthermore, loss of CDKN1B expression increases susceptibility to gastric carcinogenesis in H. pylori-infected CDKN1B-knockout mice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Epigenetic events",
"      </strong>",
"      &ndash; Epigenetic alterations such as DNA methylation of gene promoters can silence the expression of certain genes, including",
"      <em>",
"       CDH1",
"      </em>",
"      (the E-cadherin gene) in intestinal-type cancers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/51,63,82,83\">",
"       51,63,82,83",
"      </a>",
"      ]. At least some data suggest that aberrant promoter methylation may be closely associated with H. pylori infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/84-87\">",
"       84-87",
"      </a>",
"      ] and that higher methylation levels correlate with higher risk for invasive cancers. The effects seem to be reversible after the bacteria are no longer present [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/87,88\">",
"       87,88",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      On the other hand, aberrant methylation increases with normal aging and is also present in nonmalignant conditions such chronic infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/89\">",
"       89",
"      </a>",
"      ]. Aberrant methylation is also more frequent in patients with multiple cancers than in those with a single adenocarcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/86\">",
"       86",
"      </a>",
"      ]. These findings suggest that aberrant methylation may be a precursor of tumor development, acting as a \"field defect\" in gastric carcinogenesis.",
"      <br/>",
"      <br/>",
"      Hypermethylation of the",
"      <em>",
"       Reprimo",
"      </em>",
"      gene has been found not only in the gastric tumors but also in the plasma of patients with gastric cancer, raising the possibility of blood-derived biomarkers in the detection of &ldquo;early&rdquo; gastric cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/90\">",
"       90",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"       \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sequential accumulation of genetic abnormalities may result in a neoplastic phenotype in gastric cancer. However, the invasion capability of the neoplastic cells may also be related to extracellular matrix degradation that facilitates invasion. Urokinase plasminogen activator (uPAR) is involved in matrix degradation and is expressed in gastric cancer cells as well as in macrophages and myofibroblasts of the invasion front [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/91\">",
"     91",
"    </a>",
"    ]. As such, uPAR may be a useful biomarker of cancer invasion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Beta-catenin/Wnt signaling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The orderly sequential accumulation of genetic abnormalities as an explanation for cancer development is being challenged, even in colorectal cancer (CRC). It is increasingly recognized that tumor progression for CRC as well as other cancers is characterized by a temporary loss of cellular differentiation (an epithelial-mesenchymal transition) at the leading edge of invading tumor cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/92\">",
"     92",
"    </a>",
"    ]. Once established, the invading cells then redifferentiate from mesenchymal to epithelial phenotypes. This dynamic process of dedifferentiation, invasion, and redifferentiation cannot be explained solely by the accumulation of stable, irreversible genetic alterations, leading some to suggest that it is regulated by the tumor microenvironment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The molecular abnormalities found in cells from the \"advancing\" edge of carcinomas differ from those of the cells showing tubulo-glandular formation. A major difference is the pattern of expression of beta-catenin (",
"    <a class=\"graphic graphic_picture graphicRef72963 \" href=\"mobipreview.htm?29/1/29719\">",
"     picture 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef69220 \" href=\"mobipreview.htm?35/37/36438\">",
"     picture 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Beta-catenin is a critical component of the Wnt signaling pathway which, during embryonic development, regulates morphogenesis. Tissue morphogenesis is a process that demands temporal and spatial coordination of individual events such as intercellular adhesion junctions, migration, proliferation, and differentiation.",
"   </p>",
"   <p>",
"    Beta catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/96\">",
"     96",
"    </a>",
"    ]. The basics of the",
"    <span class=\"nowrap\">",
"     beta-catenin/Wnt",
"    </span>",
"    signaling pathway are as follows. In normal mucosa and well-differentiated tumor cells, beta-catenin is normally bound to protein complexes in the cell membrane that are involved in normal intercellular adhesions (",
"    <a class=\"graphic graphic_picture graphicRef72963 \" href=\"mobipreview.htm?29/1/29719\">",
"     picture 6",
"    </a>",
"    ). These complexes (",
"    <a class=\"graphic graphic_picture graphicRef52941 \" href=\"mobipreview.htm?40/1/40983\">",
"     picture 8",
"    </a>",
"    ) maintain cell-to-cell adhesions and the cellular polarity that is required for tubulo-glandular formation.",
"   </p>",
"   <p>",
"    As long as Wnt signaling is inactive, cytoplasmic beta-catenin is either bound to an",
"    <span class=\"nowrap\">",
"     APC/axin/conductin",
"    </span>",
"    complex or degraded. Within the cytoplasm, the protein product of the wild-type APC gene prevents the accumulation of beta-catenin by mediating its phosphorylation and resultant degradation within proteosomes.",
"   </p>",
"   <p>",
"    When activating mutations are present in a component of the Wnt pathway (such as in sporadic CRCs which have APC mutations or mutations in beta-catenin itself, (",
"    <a class=\"graphic graphic_figure graphicRef72022 \" href=\"mobipreview.htm?31/17/32019\">",
"     figure 3",
"    </a>",
"    )) this leads to loss of regulation of beta-catenin. The end result is cytoplasmic accumulation of beta-catenin, nuclear translocation, and constitutive activation of transcription by a",
"    <span class=\"nowrap\">",
"     beta-cetenin/T-cell",
"    </span>",
"    factor (Tcf) complex. Among the target genes whose transcription is turned on by the",
"    <span class=\"nowrap\">",
"     beta-catenin/TCF",
"    </span>",
"    complex include those that stimulate proliferation, angiogenesis, tumor invasion, and metastasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/95,97\">",
"     95,97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link&amp;anchor=H13#H13\">",
"     \"Molecular genetics of colorectal cancer\", section on 'APC gene'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, it has been proposed that gastric carcinogenesis involves an initial stage of dedifferentiation (gastric atrophy), followed by abnormal redifferentiation (intestinal metaplasia) and that this process is mediated by the effect of H. pylori infection (particularly CagA-containing strains) on beta-catenin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/93,98\">",
"     93,98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations provide support for this model of gastric carcinogenesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are major differences in gastric cancer risk among different strains of H. pylori. Strains carrying virulence factors such as CagA and vacA s1 and m1 are more frequently associated with severe gastritis, precancerous lesions, and gastric cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/99-101\">",
"       99-101",
"      </a>",
"      ]. In vitro, CagA expression alone is sufficient to disrupt apical junctions and perturb the mechanisms that maintain normal epithelial differentiation, including cell adhesion, cell polarity, and the inhibition of migration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/102\">",
"       102",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H6#H6\">",
"       \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'H. pylori strain differences'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Others have shown that CagA can induce proteolytic cleavage of E-cadherin, disrupting E-cadherin-dependent cell to cell contact [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/103\">",
"       103",
"      </a>",
"      ], and that it impairs the complex formation between E-cadherin and beta-catenin, causing cytoplasmic and nuclear accumulation of beta-catenin and constitutive transcription of markers of intestinal differentiation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/95,104,105\">",
"       95,104,105",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an animal model in which gerbils were infected with a rodent-adapted strain of oncogenic CagA-producing human H. pylori, gastric dysplasia developed by four weeks in 88 percent, and gastric adenocarcinoma was present in 75 percent of the animals by eight weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/104\">",
"       104",
"      </a>",
"      ]. Nuclear localization of beta-catenin was observed in a human gastric cell line after infection with this same H. pylori strain, but not with the original non-carcinogenic clinical isolate (B128).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Migrating bone marrow derived cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described in the gastric precancerous cascade, epithelial cells acquire abnormal phenotypes which resemble intestinal epithelium. It has been presumed that these abnormal cells were derived from gastric stem cells located in the isthmus region of the gastric glands, the only replicating zone in the normal gastric mucosa.",
"   </p>",
"   <p>",
"    A potentially important observation is that the source of the abnormal cells may not be from gastric epithelium itself but rather from bone marrow derived cells that are attracted to the gastric mucosa and differentiate into gastric epithelial cells in the presence of H. pylori [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/106\">",
"     106",
"    </a>",
"    ]. In a series of elegant experiments, chronic infection of lethally irradiated",
"    <span class=\"nowrap\">",
"     C57BL/6",
"    </span>",
"    mice with Helicobacter felis (H. felis) induced repopulation of the stomach with BMDCs.",
"   </p>",
"   <p>",
"    Although these findings require independent confirmation, they fit well with a proposed model of carcinogenesis, which integrates aspects of Wnt signaling and bone marrow-derived stem cells that can contribute to the gastric epithelium (termed the \"migrating cancer stem cell\" concept) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/92,107-109\">",
"     92,107-109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFUSE TYPE CANCERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like intestinal-type cancers, diffuse-type gastric carcinomas can be induced by H. pylori infection. However, there are also prominent differences between these two variants. H. pylori-associated invasive intestinal-type cancers are characterized by a defined series of preneoplastic stages which are not seen with diffuse-type cancers. From an epidemiologic standpoint, both diffuse and intestinal cancers have been decreasing in incidence in most countries, although the decline is more marked for intestinal carcinomas. Intestinal carcinomas are also more frequent in men, and they are associated with a slightly better prognosis.",
"   </p>",
"   <p>",
"    Diffuse type cancers are highly metastatic and characterized by rapid disease progression and a poorer prognosis than intestinal cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/110,111\">",
"     110,111",
"    </a>",
"    ]. Diffuse carcinomas also have a greater tendency to invade the gastric wall, sometimes extending to the lower esophagus or to the duodenum. Occasionally, a broad region of the gastric wall or even the entire stomach is extensively infiltrated, resulting in a rigid thickened stomach, termed \"linitis plastica\" (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79963 \" href=\"mobipreview.htm?4/39/4723\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Histologically, individual tumor cells are seen to invade the surrounding tissues, and there is no gland formation. When intracellular mucin is abundant, it pushes aside the nucleus of the individual cells, resulting in the so-called signet ring carcinoma. It has long been thought that signet ring histology is an independent predictor of a worse prognosis as compared to other forms of gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/112,113\">",
"     112,113",
"    </a>",
"    ]. However, more recent studies have begun to question this notion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/114-118\">",
"     114-118",
"    </a>",
"    ]. Some studies suggest that signet ring histology is associated with more advanced stage of disease at presentation, and that when adjusted for stage, signet ring cancer does not portend a worse prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/116,118\">",
"     116,118",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Molecular pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike the complex and poorly understood molecular pathways that underlie carcinogenesis in intestinal-type tumors, diffuse carcinomas display a prominent molecular abnormality: defective intercellular adhesions. In most cases, this results from loss of expression of the cell adhesion protein E-cadherin. The E-cadherin gene (CDH1) encodes a homodimeric transmembrane cellular adhesion protein. Its cytoplasmic tail interacts with catenins, assembling the cell:cell adhesion complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/119\">",
"     119",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Beta-catenin/Wnt signaling'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Germline truncating mutations of the CDH1 gene, located on chromosome 16q22.1, were originally described in three Maori families from New Zealand that were predisposed to diffuse gastric cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/120\">",
"     120",
"    </a>",
"    ]. Subsequently germline mutations have been identified in many other kindreds worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/121\">",
"     121",
"    </a>",
"    ]. These mutations are not concentrated in a single hotspot, but rather evenly distributed along the gene in several different exons. The trigger and molecular mechanism by which the second allele of E-cadherin is inactivated appears to be diverse, and includes promoter hypermethylation, mutation, and loss of heterozygosity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/122,123\">",
"     122,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Mendelian Inheritance in Man (MIM) number for germline mutations in the CDH1 gene is 192090; there is also useful discussion of other mutations in gastric cancer at 137215. The MIM database of human genes and genetic disorders can be accessed through the National Center for Biotechnology Information at",
"    <a class=\"external\" href=\"file://www.ncbi.nih.gov/sites/entrez?db=OMIM\">",
"     www.ncbi.nih.gov/sites/entrez?db=OMIM",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    HDGC has an autosomal dominant pattern of inheritance, with early onset gastric cancers in the majority of affected individuals. The lifetime cumulative risk for clinically significant gastric cancer in individuals from these families is &gt;80 percent in both men and women by age 80 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/124\">",
"     124",
"    </a>",
"    ]. The early gastric cancers that develop in these individuals are often multifocal and located beneath an intact mucosal surface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/125\">",
"     125",
"    </a>",
"    ]. Because of the difficulty in early detection and the poor prognosis of these tumors when locoregionally advanced, patients with evidence of a",
"    <em>",
"     CDH1",
"    </em>",
"    germline mutation in the context of a family history of HDGC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/126\">",
"     126",
"    </a>",
"    ] are candidates for prophylactic gastrectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link&amp;anchor=H23#H23\">",
"     \"Risk factors for gastric cancer\", section on 'Hereditary diffuse gastric cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Affected women are also at an increased risk of lobular breast cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=see_link\">",
"     \"Pathology of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abnormalities in",
"    <em>",
"     CDH1",
"    </em>",
"    have also been linked to sporadic diffuse (and intestinal) carcinomas. Somatic mutations in the",
"    <em>",
"     CDH1",
"    </em>",
"    gene are identified in 40 to 83 percent of sporadic diffuse-type gastric cancers, and promoter hypermethylation is also reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/127-130\">",
"     127-130",
"    </a>",
"    ]. One analysis of 174 sporadic gastric cancers found that",
"    <em>",
"     CDH1",
"    </em>",
"    alterations (both structural alterations such as mutations or loss of heterozygosity and epigenetic alterations) were present in 34 percent of diffuse-type gastric cancers and 26 percent of intestinal cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/83\">",
"     83",
"    </a>",
"    ]. This analysis found no structural alterations among 19 patients with HDGC, but 53 percent harbored an epigenetic methylation.",
"   </p>",
"   <p>",
"    Thus, the",
"    <em>",
"     CDH1",
"    </em>",
"    gene appears to function as a tumor suppressor gene and its inactivation follows the classical \"two hit\" model. While biallelic inactivation can occur through germline or somatic mutation or the",
"    <em>",
"     CDH1",
"    </em>",
"    gene or allelic imbalance events (ie, loss of heterozygosity [LOH]), the second allele is commonly inactivated by CDH1 promoter hypermethylation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/129,131\">",
"     129,131",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Susceptibility to diffuse gastric cancer may also be linked to inherited polymorphisms in the",
"    <em>",
"     PSCA",
"    </em>",
"    (prostate stem cell antigen) gene, which is possibly involved in regulating gastric epithelial cell proliferation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/132\">",
"     132",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Preneoplastic lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to intestinal-type cancers, diffuse carcinomas do not have a clearly defined precancerous lesion, even those that are associated with H. pylori infection.",
"   </p>",
"   <p>",
"    Histologic analysis of early HDGC cases has led to a progression model for the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/4\">",
"     4",
"    </a>",
"    ]. In gastrectomy specimens from members of cancer families, isolated neoplastic signet ring cells are seen at the base of glands, representing an \"in situ\" carcinoma. Neoplastic cells extend within the epithelium in a \"pagetoid\" fashion and then invade the stroma in multiple foci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    H. pylori seems not to play any role in HDGC. A role for H. pylori in sporadic tumors has been suggested (since infection increases the risk for both intestinal and diffuse histologic subtypes), but no mechanistic studies have been published. As noted above, CagA does damage E-cadherin in experimental animal models, but it does not lead to the diffuse type of gastric carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/104\">",
"     104",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Beta-catenin/Wnt signaling'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CLINICAL IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is hoped that advances in the understanding of the events that underlie gastric carcinogenesis will lead to advances in treatment and prevention. An example of a therapeutic gain from progress in knowledge about molecular pathogenesis is the identification of germline CDH1 mutations in families with an inherited propensity to diffuse gastric cancers. At-risk individuals can now be identified and targeted for potentially lifesaving prophylactic total gastrectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2296?source=see_link\">",
"     \"Hereditary diffuse gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3625?source=see_link\">",
"     \"Prophylactic total gastrectomy for hereditary diffuse gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The identification of growth patterns and molecular abnormalities has also led to differences in the surgical approach to treatment of invasive gastric carcinomas. While most intestinal-type cancers can be treated with subtotal gastrectomy, total gastrectomy is usually recommended for diffuse cancers because of their tendency to invade locally and extend to the duodenum or lower esophagus. As noted above, for hereditary diffuse gastric cancer, the multicentricity and lethal outcome at relatively younger ages has led to the adoption of prophylactic total gastrectomy after age 20 in family members with documented CDH1 mutations.",
"   </p>",
"   <p>",
"    The most promising strategy to control gastric cancer mortality worldwide is through prevention. This statement is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H. pylori infection is the primary cause of gastric cancer and is a risk factor for both the diffuse and intestinal types. At least in the case of intestinal-type cancers, there is a prolonged precancerous process which takes decades to progress from infection to cancer.",
"     </li>",
"     <li>",
"      There is a better understanding of H. pylori virulence factors such as CagA, VacAs1m1 and the Eastern pattern of EPIYA motifs in the cagA gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/134\">",
"       134",
"      </a>",
"      ], some of which can now be identified by non-invasive methods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/135,136\">",
"       135,136",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Identifiable markers of genetic susceptibility to gastric carcinogenesis among H. pylori-infected individuals in specific populations are increasingly being recognized. These include inherited polymorphisms in the interleukin (IL)-1-beta gene in individuals of European ancestry, methylene tetrahydrofolate (MTHFR) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/137\">",
"       137",
"      </a>",
"      ], and IL-8 genes in Asians [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/138,139\">",
"       138,139",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link&amp;anchor=H24#H24\">",
"       \"Risk factors for gastric cancer\", section on 'Genetic polymorphisms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The Japanese experience, which demonstrates that removing dysplasias and early cancers discovered by gastroscopic screening monitoring results in decreased mortality. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6983?source=see_link&amp;anchor=H3#H3\">",
"       \"Screening and prevention of gastric cancer\", section on 'Effectiveness'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=see_link\">",
"       \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Effective anti H. pylori therapy is associated with a reduction in cell proliferation, resolution of the inflammatory response, disappearance of hyperplastic polyps, normalization of the apoptotic rate, and regression of glandular atrophy and intestinal metaplasia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    H. pylori is classified as a carcinogen for stomach cancer by the WHO, and an Asian-Pacific consensus conference in 2007 concluded that population-based screening and antibiotic treatment of H. pylori in high-risk populations is now recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/140\">",
"     140",
"    </a>",
"    ], a viewpoint that is shared by others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/141\">",
"     141",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Eradication of H. pylori has been proposed as a means to prevent gastric cancer by inducing regression or preventing progression of premalignant lesions (gastric atrophy, intestinal metaplasia, and dysplasia) in infected patients. Eradication therapy can induce regression of premalignant lesions and decrease the rate of progression; however, up to 45 percent of patients can still show progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/142\">",
"     142",
"    </a>",
"    ]. A strategy has been proposed to prevent gastric cancer in subjects in whom a diagnosis of intestinal metaplasia has been made in a gastric biopsy. In such cases, two characteristics of the metaplastic lesion determine the management of the patient. If the metaplasia is very extensive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    it is classified as &ldquo;incomplete&rdquo; &ldquo;colonic&rdquo; type, endoscopic monitoring is indicated. If during the follow up a diagnosis of high grade dysplasia or of &ldquo;early&rdquo; (intramucosal) carcinoma is made, surgical or endoscopic resection of the lesion should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/143\">",
"     143",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The success of this approach is illustrated by data demonstrating that eradication of H. pylori appears to reduce the risk of gastric cancer in high-risk populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis that included seven controlled trials (all in areas with a high incidence of gastric cancer) found significantly lower rates of gastric cancer (1.1 versus 1.7 percent) in patients who were randomly assigned to eradication versus no eradiation of H pylori (RR 0.65, 95% CI 0.43-0.98) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/144\">",
"       144",
"      </a>",
"      ]. In one of these trials, benefit was seen in patients who had already developed early gastric cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/145\">",
"       145",
"      </a>",
"      ]; the impact on survival was not addressed. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H11#H11\">",
"       \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Does treatment reduce risk of gastric cancer?'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/46/4842?source=see_link&amp;anchor=H757936026#H757936026\">",
"       \"Early gastric cancer: Treatment, natural history, and prognosis\", section on 'Anti-Helicobacter therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The first evidence from a single trial demonstrating the value of anti-Helicobacter pylori treatment to prevent gastric cancer was provided by a Chinese trial in which a cohort of 3365 subjects were randomly assigned to receive or not receive",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      to eradicate the infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/146\">",
"       146",
"      </a>",
"      ]. At the end of 14.7 years of follow up, there was a 39 percent reduction in the incidence of gastric cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/146\">",
"       146",
"      </a>",
"      ]. The number of gastric cancer deaths was also lower in the treated group, but the difference was not statistically significant (HR for death 0.67, 95% CI 0.36-1.28).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even if treatment does reduce the gastric cancer risk, difficulties with screening and treatment arise. Widespread adoption of screening and treatment for H. pylori in non-high-risk populations is limited by cost, which would be tremendous given the worldwide prevalence of H. pylori infection. Issues regarding cost-effectiveness of screening and treating H. pylori infection are addressed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H11#H11\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Does treatment reduce risk of gastric cancer?'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another potentially effective approach to reduction of gastric cancer incidence in patients with gastric ulcers who are infected with H. pylori is regular use of NSAIDs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/26/33194/abstract/147\">",
"     147",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30165966\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric adenocarcinoma is one of the few malignant neoplasms for which infectious agents have been recognized as having an important etiologic role. Helicobacter pylori (H. pylori) infection is the primary cause of gastric cancer.",
"   </p>",
"   <p>",
"    There are two distinct types of gastric adenocarcinoma, intestinal (well-differentiated) and diffuse (undifferentiated), which have distinct morphologic appearance, pathogenesis, and genetic profiles (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Intestinal versus diffuse types'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lack of adhesion molecules in diffuse carcinomas allows the individual tumor cells to grow and invade neighboring structures without the formation of tubules or glands. Diffuse type cancers are highly metastatic and characterized by rapid disease progression and a poor prognosis.",
"      <br/>",
"      <br/>",
"      The main carcinogenic event is loss of expression of E-cadherin, a key cell surface protein for establishing intercellular connections. Biallelic inactivation of the gene encoding E-cadherin, CDH1, can occur through germline or somatic mutation, allelic imbalance events (eg, loss of heterozygosity), or epigenetic silencing of gene transcription. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diffuse type cancers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In direct contrast, the pathogenesis of intestinal-type gastric cancers is less well defined. However, it appears to follow a multistep progression that is usually initiated by H. pylori infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Intestinal type cancers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although diffuse-type cancers can also be induced by H pylori, H. pylori-associated invasive intestinal-type cancers are characterized by a defined series of preneoplastic stages which are not seen with diffuse-type cancers. At least in the case of intestinal-type cancers, there is a prolonged precancerous process that takes decades to progress from infection to cancer. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'H. pylori and the preneoplastic cascade'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Eradication of H. pylori has been proposed as a means to prevent gastric cancer by inducing regression or preventing progression of premalignant lesions (gastric atrophy, intestinal metaplasia, and dysplasia) in infected patients. In a meta-analysis, eradication of H. pylori appeared to significantly reduce the risk of gastric cancer in high-risk populations. Population-based screening and antibiotic treatment of H. pylori in high-risk populations is now recommended. &nbsp;",
"   </p>",
"   <p>",
"    Widespread adoption of screening and treatment for H. pylori in non-high-risk populations is limited by cost, which would be tremendous given the worldwide prevalence of H. pylori infection. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Clinical implications'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link&amp;anchor=H11#H11\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\", section on 'Does treatment reduce risk of gastric cancer?'",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/1\">",
"      Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/2\">",
"      IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC 1994; 61:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/3\">",
"      Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20 Suppl 1:S8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/4\">",
"      Carneiro F, Huntsman DG, Smyrk TC, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004; 203:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/5\">",
"      Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/6\">",
"      Koriyama C, Akiba S, Corvalan A, et al. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan. Oncol Rep 2004; 12:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/7\">",
"      Carrascal E, Koriyama C, Akiba S, et al. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia. Oncol Rep 2003; 10:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/8\">",
"      Corvalan A, Koriyama C, Akiba S, et al. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer 2001; 94:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/9\">",
"      Correa P. Gastric cancer: two epidemics? Dig Dis Sci 2011; 56:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/10\">",
"      LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand 1965; 64:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/11\">",
"      Shah MA, Khanin R, Tang L, et al. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17:2693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/12\">",
"      Tan IB, Ivanova T, Lim KH, et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 2011; 141:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/13\">",
"      Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999; 79:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/14\">",
"      Henson DE, Dittus C, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/15\">",
"      Locke GR 3rd, Talley NJ, Carpenter HA, et al. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995; 109:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/16\">",
"      Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/17\">",
"      Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/18\">",
"      Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/19\">",
"      Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985; 26:1319.",
"     </a>",
"    </li>",
"    <li>",
"     Tumours of the Digestive System. In: World Health Organization Classification of Tumours: Pathology and Genetics, Hamilton SR, Aaltonen LA (Eds), IARC Press, Lyon, France 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/21\">",
"      Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/22\">",
"      de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/23\">",
"      El-Rifai W, Frierson HF Jr, Moskaluk CA, et al. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology 2001; 121:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/24\">",
"      Stocks SC, Pratt N, Sales M, et al. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas. Genes Chromosomes Cancer 2001; 32:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/25\">",
"      Yanagi M, Keller G, Mueller J, et al. Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach. Virchows Arch 2000; 437:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/26\">",
"      Tajima Y, Nakanishi Y, Yoshino T, et al. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 2001; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/27\">",
"      Sim&aacute;n JH, Engstrand L, Berglund G, et al. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 2007; 42:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/28\">",
"      Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/29\">",
"      Tajima Y, Yamazaki K, Makino R, et al. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 2007; 96:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/30\">",
"      Piazuelo MB, Haque S, Delgado A, et al. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol 2004; 17:62.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.117.",
"    </li>",
"    <li>",
"     Japanese Classification of Gastric Carcinoma. In: Gastric Cancer, 2nd, Japanese Gastric Cancer Association, 1998. p.10.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/33\">",
"      Sayegh ME, Sano T, Dexter S, et al. TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer 2004; 7:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/34\">",
"      Kunisaki C, Shimada H, Nomura M, et al. Comparative evaluation of gastric carcinoma staging: Japanese classification versus new american joint committee on cancer/international union against cancer classification. Ann Surg Oncol 2004; 11:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/35\">",
"      An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993; 341:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/36\">",
"      Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/37\">",
"      Parsonnet J, Vandersteen D, Goates J, et al. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/38\">",
"      Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/39\">",
"      Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/40\">",
"      Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/41\">",
"      Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/42\">",
"      Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56:3238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/43\">",
"      Pignatelli B, Bancel B, Est&egrave;ve J, et al. Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans. Eur J Cancer Prev 1998; 7:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/44\">",
"      Asim A, Chaturvedi R, Piazuelo MB, et al. Helicobacter pylori strains from regions at high gastric cancer risk exhibit increased ability to activate iNOS and SMO. Gastroenterology 2008; 134(suppl 1):A78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/45\">",
"      Achtman M, Azuma T, Berg DE, et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol 1999; 32:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/46\">",
"      Falush D, Wirth T, Linz B, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/47\">",
"      de Sablet T, Piazuelo MB, Shaffer CL, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011; 60:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/48\">",
"      Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/49\">",
"      Loh JT, Shaffer CL, Piazuelo MB, et al. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev 2011; 20:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/50\">",
"      Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/51\">",
"      Yasui W, Sentani K, Motoshita J, Nakayama H. Molecular pathobiology of gastric cancer. Scand J Surg 2006; 95:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/52\">",
"      Yasui W, Oue N, Kuniyasu H, et al. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001; 4:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/53\">",
"      Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12:2979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/54\">",
"      Churin Y, Al-Ghoul L, Kepp O, et al. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003; 161:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/55\">",
"      Morgan C, Jenkins GJ, Ashton T, et al. Detection of p53 mutations in precancerous gastric tissue. Br J Cancer 2003; 89:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/56\">",
"      Shiao YH, Rugge M, Correa P, et al. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/57\">",
"      Yokozaki H, Shitara Y, Fujimoto J, et al. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int J Cancer 1999; 83:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/58\">",
"      Tomkova K, Belkhiri A, El-Rifai W, Zaika AI. p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res 2004; 64:6390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/59\">",
"      Ushiku T, Chong JM, Uozaki H, et al. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2007; 120:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/60\">",
"      Li JH, Shi XZ, Lv S, et al. Effect of Helicobacter pylori infection on p53 expression of gastric mucosa and adenocarcinoma with microsatellite instability. World J Gastroenterol 2005; 11:4363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/61\">",
"      Kodama M, Fujioka T, Murakami K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol 2005; 20:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/62\">",
"      Ashktorab H, Ahmed A, Littleton G, et al. p53 and p14 increase sensitivity of gastric cells to H. pylori-induced apoptosis. Dig Dis Sci 2003; 48:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/63\">",
"      Devereux TR, Stockton P, Sun K, et al. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol 2001; 53:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/64\">",
"      Sato K, Tamura G, Tsuchiya T, et al. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Cancer 2001; 85:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/65\">",
"      Xiao YP, Wu DY, Xu L, Xin Y. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma. World J Gastroenterol 2006; 12:3766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/66\">",
"      Noguchi T, M&uuml;ller W, Wirtz HC, et al. FHIT gene in gastric cancer: association with tumour progression and prognosis. J Pathol 1999; 188:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/67\">",
"      Baffa R, Veronese ML, Santoro R, et al. Loss of FHIT expression in gastric carcinoma. Cancer Res 1998; 58:4708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/68\">",
"      Lee SH, Kim WH, Kim HK, et al. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem Biophys Res Commun 2001; 284:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/69\">",
"      Kodama M, Murakami K, Okimoto T, et al. Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol 2007; 13:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/70\">",
"      Staib F, Robles AI, Varticovski L, et al. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res 2005; 65:10255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/71\">",
"      Fang DC, Luo YH, Yang SM, et al. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol 2002; 8:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/72\">",
"      Nakatsuru S, Yanagisawa A, Furukawa Y, et al. Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum Mol Genet 1993; 2:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/73\">",
"      Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/74\">",
"      Wu MS, Shun CT, Wang HP, et al. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. Jpn J Cancer Res 1998; 89:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/75\">",
"      Leung WK, Yu J, Chan FK, et al. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 2002; 197:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/76\">",
"      Akama Y, Yasui W, Yokozaki H, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/77\">",
"      Bani-Hani KE, Almasri NM, Khader YS, et al. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Clin Cancer Res 2005; 11:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/78\">",
"      Sun Y, Li JY, He JS, et al. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 2005; 46:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/79\">",
"      Takano Y, Kato Y, van Diest PJ, et al. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000; 156:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/80\">",
"      So JB, Samarasinge K, Raju GC, et al. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients. J Surg Res 2000; 94:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/81\">",
"      Kuzushita N, Rogers AB, Monti NA, et al. p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 2005; 129:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/82\">",
"      Leal M, Lima E, Silva P, et al. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol 2007; 13:2568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/83\">",
"      Corso G, Carvalho J, Marrelli D, et al. Somatic mutations and deletions of the e-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol 2013; 31:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/84\">",
"      Tahara T, Arisawa T, Shibata T, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion 2007; 75:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/85\">",
"      Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/86\">",
"      Nakajima T, Maekita T, Oda I, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 2006; 15:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/87\">",
"      Leung WK, Man EP, Yu J, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006; 12:3216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/88\">",
"      Peek RM Jr, Schneider BG, Correa P. Coming unglued. Clin Cancer Res 2006; 12:2951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/89\">",
"      Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J Gastroenterol 2006; 41:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/90\">",
"      Bernal C, Aguayo F, Villarroel C, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res 2008; 14:6264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/91\">",
"      Alp&iacute;zar-Alp&iacute;zar W, Nielsen BS, Sierra R, et al. Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries. Int J Cancer 2010; 126:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/92\">",
"      Brabletz T, Jung A, Spaderna S, et al. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/93\">",
"      Hlubek F, Spaderna S, Schmalhofer O, et al. Wnt/FZD signaling and colorectal cancer morphogenesis. Front Biosci 2007; 12:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/94\">",
"      Brabletz T, Jung A, Kirchner T. Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002; 441:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/95\">",
"      Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26:4617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/96\">",
"      Clements WM, Wang J, Sarnaik A, et al. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002; 62:3503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/97\">",
"      Lowy AM, Clements WM, Bishop J, et al. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006; 66:4734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/98\">",
"      Faller G, Kirchner T. Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 2005; 446:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/99\">",
"      Miehlke S, Kirsch C, Agha-Amiri K, et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000; 87:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/100\">",
"      Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/101\">",
"      Plummer M, van Doorn LJ, Franceschi S, et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007; 99:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/102\">",
"      Bagnoli F, Buti L, Tompkins L, et al. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 2005; 102:16339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/103\">",
"      Weydig C, Starzinski-Powitz A, Carra G, et al. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp Cell Res 2007; 313:3459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/104\">",
"      Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005; 102:10646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/105\">",
"      Suzuki M, Mimuro H, Suzuki T, et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 2005; 202:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/106\">",
"      Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/107\">",
"      Okumura T, Wang SS, Takaishi S, et al. Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium. Lab Invest 2009; 89:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/108\">",
"      Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol 2008; 26:2876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/109\">",
"      Li HC, Stoicov C, Rogers AB, Houghton J. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006; 12:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/110\">",
"      Yashiro M, Chung YS, Nishimura S, et al. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer 1995; 72:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/111\">",
"      Kunz PL, Gubens M, Fisher GA, et al. Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol 2012; 30:3507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/112\">",
"      Piessen G, Messager M, Leteurtre E, et al. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 2009; 250:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/113\">",
"      Ribeiro MM, Sarmento JA, Sobrinho Sim&otilde;es MA, Bastos J. Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer 1981; 47:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/114\">",
"      Zhang M, Zhu G, Zhang H, et al. Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg 2010; 14:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/115\">",
"      Kunisaki C, Shimada H, Nomura M, et al. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg 2004; 91:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/116\">",
"      Kim DY, Park YK, Joo JK, et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg 2004; 74:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/117\">",
"      Hyung WJ, Noh SH, Lee JH, et al. Early gastric carcinoma with signet ring cell histology. Cancer 2002; 94:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/118\">",
"      Taghavi S, Jayarajan SN, Davey A, Willis AI. Prognostic significance of signet ring gastric cancer. J Clin Oncol 2012; 30:3493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/119\">",
"      Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003; 14:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/120\">",
"      Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/121\">",
"      Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58:4086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/122\">",
"      Barber M, Murrell A, Ito Y, et al. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/123\">",
"      Oliveira C, Sousa S, Pinheiro H, et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009; 136:2137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/124\">",
"      Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010; 47:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/125\">",
"      Charlton A, Blair V, Shaw D, et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004; 53:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/126\">",
"      Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/127\">",
"      Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21:8192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/128\">",
"      Ramos-de la Medina A, More H, Medina-Franco H, et al. Single nucleotide polymorphisms (SNPs) at CDH1 promoter region in familial gastric cancer. Rev Esp Enferm Dig 2006; 98:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/129\">",
"      Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/130\">",
"      Tamura G, Yin J, Wang S, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/131\">",
"      Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20:1525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/132\">",
"      Study Group of Millennium Genome Project for Cancer, Sakamoto H, Yoshimura K, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008; 40:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/133\">",
"      Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006; 14:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/134\">",
"      Naito M, Yamazaki T, Tsutsumi R, et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006; 130:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/135\">",
"      Cover TL, Glupczynski Y, Lage AP, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995; 33:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/136\">",
"      Ghose C, Perez-Perez GI, Torres VJ, et al. Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2. Clin Vaccine Immunol 2007; 14:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/137\">",
"      Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006; 51:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/138\">",
"      Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/139\">",
"      Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14:2487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/140\">",
"      Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/141\">",
"      Talley NJ. Is it time to screen and treat H pylori to prevent gastric cancer? Lancet 2008; 372:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/142\">",
"      Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/143\">",
"      Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/144\">",
"      Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009; 151:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/145\">",
"      Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/146\">",
"      Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/26/33194/abstract/147\">",
"      Wu CY, Wu MS, Kuo KN, et al. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010; 28:2952.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2498 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.65.66-4367187BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33194=[""].join("\n");
var outline_f32_26_33194=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30165966\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Intestinal versus diffuse types",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INTESTINAL TYPE CANCERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      H. pylori and the preneoplastic cascade",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Non-atrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Atrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Intestinal metaplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H646035135\">",
"      Asian versus Western nomenclature",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Invasive carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H646035157\">",
"      Histologic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Models of molecular pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Sequential accumulation of genetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Beta-catenin/Wnt signaling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Migrating bone marrow derived cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFUSE TYPE CANCERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Molecular pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Preneoplastic lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CLINICAL IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30165966\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2498\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2498|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/39/4723\" title=\"diagnostic image 1\">",
"      Linitis plastica UGI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2498|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/45/4817\" title=\"figure 1\">",
"      Parts of the stomach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/0/17409\" title=\"figure 2\">",
"      SEER survival gast CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/17/32019\" title=\"figure 3\">",
"      APC and wnt signaling pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2498|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/47/29434\" title=\"picture 1\">",
"      Nonatrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/19/36153\" title=\"picture 2\">",
"      Multifoc atroph gastritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/30/34277\" title=\"picture 3\">",
"      Complete metaplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/7/40054\" title=\"picture 4\">",
"      Incomplete metaplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/54/34662\" title=\"picture 5\">",
"      Low grade dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/1/29719\" title=\"picture 6\">",
"      Well different beta catenin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/37/36438\" title=\"picture 7\">",
"      Invasive beta catenin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/1/40983\" title=\"picture 8\">",
"      Well different E cadherin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2498|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/24/15756\" title=\"table 1\">",
"      Class gastric ca precurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/27/8637\" title=\"table 2\">",
"      WHO class gastric ca",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/6/11374\" title=\"table 3\">",
"      2010 TNM staging stomach CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=related_link\">",
"      Association between Helicobacter pylori infection and gastrointestinal malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31205?source=related_link\">",
"      Classification and diagnosis of gastritis and gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37033?source=related_link\">",
"      Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/46/4842?source=related_link\">",
"      Early gastric cancer: Treatment, natural history, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4661?source=related_link\">",
"      Epidemiology of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2296?source=related_link\">",
"      Hereditary diffuse gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/15/33018?source=related_link\">",
"      Invasive gastric cancer: Surgery and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16040?source=related_link\">",
"      Pathology of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=related_link\">",
"      Pathophysiology of and immune response to Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3625?source=related_link\">",
"      Prophylactic total gastrectomy for hereditary diffuse gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6983?source=related_link\">",
"      Screening and prevention of gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_26_33195="Ethambutol weight-based dosing";
var content_f32_26_33195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=53\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=53\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Weight-based* dosing recommendations for ethambutol",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        40 to 55 kg",
"       </td>",
"       <td class=\"subtitle1\">",
"        56 to 75 kg",
"       </td>",
"       <td class=\"subtitle1\">",
"        76 to 90 kg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Daily, mg (mg/kg)",
"       </td>",
"       <td>",
"        800",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1600",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        (14.5 to 20.0)",
"       </td>",
"       <td>",
"        (16.0 to 21.4)",
"       </td>",
"       <td>",
"        (17.8 to 21.1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Thrice weekly, mg (mg/kg)",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        2400",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        (21.8 to 30.0)",
"       </td>",
"       <td>",
"        (26.7 to 35.7)",
"       </td>",
"       <td>",
"        (26.7 to 31.6)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Twice weekly, mg (mg/kg)",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        2800",
"       </td>",
"       <td>",
"        4000",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        (36.4 to 50.0)",
"       </td>",
"       <td>",
"        (37.3 to 50.0)",
"       </td>",
"       <td>",
"        (44.4 to 52.6)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Estimated lean body weight should be utilized.",
"     <br>",
"      &bull;&nbsp;Maximum doses regardless of weight.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33195=[""].join("\n");
var outline_f32_26_33195=null;
var title_f32_26_33196="Characteristic features of congenital infections";
var content_f32_26_33196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations that are suggestive of specific congenital infections in the neonate",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Congenital cytomegalovirus",
"       </td>",
"       <td>",
"        Periventricular intracranial calcifications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Microcephaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Congenital herpes simplex virus",
"       </td>",
"       <td>",
"        Mucocutaneous vesicles or scarring",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CSF pleocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated liver transaminases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conjunctivitis or keratoconjuctivitis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Congenital rubella",
"       </td>",
"       <td>",
"        Cataracts, congenital glaucoma, pigmentary retinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital heart disease (most commonly patent ductus arteriosus or peripheral pulmonary artery stenosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiolucent bone disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sensorineural hearing loss",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Congenital syphilis",
"       </td>",
"       <td>",
"        Skeletal abnormalities (osteochondritis and periostitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudoparalysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Persistent rhinitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maculopapular rash (particularly on palms and soles or in diaper area)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Congenital toxoplasmosis",
"       </td>",
"       <td>",
"        Intracranial calcifications (diffuse)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrocephalus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chorioretinitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Otherwise unexplained mononuclear CSF pleocytosis or elevated CSF protein",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Congenital varicella",
"       </td>",
"       <td>",
"        Cicatricial or vesicular skin lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limb hypoplasia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CSF: cerebrospinal fluid.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Maldonado YA, Nizet V, Klein JO, et al. Current concepts of infections of the fetus and newborn infant. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Saunders, Philadelphia 2011. p.2.",
"      </li>",
"      <li>",
"       Sanchez PJ, Demmler-Harrison GJ. Viral infections of the fetus and newborn. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed. Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.895.",
"      </li>",
"      <li>",
"       Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am 1994; 41:1017.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33196=[""].join("\n");
var outline_f32_26_33196=null;
var title_f32_26_33197="Suicide resources A";
var content_f32_26_33197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69075%7EPEDS%2F78512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69075%7EPEDS%2F78512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suicide resources",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"       In an emergency, call 1-800-SUICIDE (1-800-784-2433), the national suicide hotline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        American Academy of Child and Adolescent Psychiatry",
"       </p>",
"       <p>",
"        www.aacap.org",
"       </p>",
"       <p>",
"        202-966-7300",
"       </p>",
"      </td>",
"      <td>",
"       Provides information about developmental, behavioral, and mental disorders",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        American Association of Suicidology",
"       </p>",
"       <p>",
"        www.suicidology.org",
"       </p>",
"       <p>",
"        202-237-2280",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Provides information on current research, prevention, ways to help a suicidal person, and surviving suicide. A list of crisis centers is also included.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        American Foundation for Suicide Prevention",
"       </p>",
"       <p>",
"        www.afsp.org",
"       </p>",
"       <p>",
"        888-333-AFSP (2377)",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Provides research, education, and current statistics regarding suicide; links to other suicide and mental health sites are offered.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        American Psychiatric Association",
"       </p>",
"       <p>",
"        www.psych.org",
"       </p>",
"       <p>",
"        800-852-8330",
"       </p>",
"      </td>",
"      <td>",
"       Information and referrals to psychiatrists.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Boys Town",
"       </p>",
"       <p>",
"        www.boystown.org",
"       </p>",
"       <p>",
"        800-448-3000 (crisis hotline) or 800-545-5771",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Cares for troubled children - both boys and girls - and for families in crisis. Their hotline staff is trained to handle calls and questions about violence and suicide.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Centers for Disease Control Center for Injury Prevention and Control, Division of Violence Prevention",
"       </p>",
"       <p>",
"        www.cdc.gov/ncipc/",
"       </p>",
"       <p>",
"        770-488-4362",
"       </p>",
"      </td>",
"      <td>",
"       Provides links to suicide statistics, the SafeUSA Web site, and safety information.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        National Alliance for the Mentally Ill (NAMI)",
"       </p>",
"       <p>",
"        www.nami.org",
"       </p>",
"       <p>",
"        800-950-NAMI (6264)",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Provides information about family support and self-help groups, links to information about teen suicide, child suicide, brain biology and suicide, as well as general suicide information links.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Depression and Bipolar Support Alliance",
"       </p>",
"       <p>",
"        www.dbsalliance.org",
"       </p>",
"       <p>",
"        800-826-3632",
"       </p>",
"      </td>",
"      <td>",
"       Provides information about mood disorders including support groups and local chapters.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        National Institute of Mental Health (NIMH)",
"       </p>",
"       <p>",
"        www.nimh.nih.gov",
"       </p>",
"       <p>",
"        800-421-4211",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Provides information on depression and other mental illnesses.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: www.cdc.gov/ncipc/dvp/youth/suicide.htm and www.cdc.gov/safeusa/suicide.htm#Safety%20Resources.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suicide resources (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"       In an emergency, call 1-800-SUICIDE (1-800-784-2433), the national suicide hotline.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        National Mental Health Association (NMHA)",
"       </p>",
"       <p>",
"        www.nmha.org",
"       </p>",
"       <p>",
"        800-228-1114",
"       </p>",
"       <p>",
"        800-969-NMHA (6642)",
"       </p>",
"       <p>",
"        800-433-5959 (TTY)",
"       </p>",
"      </td>",
"      <td>",
"       Provides information on depression and its treatment and referrals to local screening sites.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        The National Mental Illness Screening Project Suicide Division",
"       </p>",
"       <p>",
"        www.nmisp.org",
"       </p>",
"       <p>",
"        800-573-4433",
"       </p>",
"      </td>",
"      <td>",
"       Provides information regarding free, confidential screening near you.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Suicide Awareness-Voices of Education (SA\VE)",
"       </p>",
"       <p>",
"        www.save.org",
"       </p>",
"       <p>",
"        612-946-7998",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Provides suicide education, facts, and statistics on suicide and depression. It links to information on warning signs of suicide and the role a friend or family member can play in helping a suicidal person.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Suicide Information &amp; Education Centre (SIEC)",
"       </p>",
"       <p>",
"        www.siec.ca",
"       </p>",
"       <p>",
"        403-245-3900",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       Library and resource center providing information on suicide and suicidal behavior.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Suicide Prevention Advocacy Network (SPAN)",
"       </p>",
"       <p>",
"        spanusa.org",
"       </p>",
"       <p>",
"        888-649-1366",
"       </p>",
"       <p>",
"        Substance Abuse and Mental Health Administration (SAMHSA) www.samhsa.gov",
"       </p>",
"      </td>",
"      <td colspan=\"1\">",
"       SPAN is a nonprofit organization dedicated to creating an effective national suicide prevention strategy. SPAN links the energy of those bereaved by suicide with the expertise of leaders in science, business, government, and public service to achieve the goal of significantly reducing the national suicide rate by the year 2010.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: www.cdc.gov/ncipc/dvp/youth/suicide.htm and www.cdc.gov/safeusa/suicide.htm#Safety%20Resources.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33197=[""].join("\n");
var outline_f32_26_33197=null;
var title_f32_26_33198="Solute removal in PD";
var content_f32_26_33198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rates of solute diffusion in peritoneal dialysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 267px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dialysate to plasma concentration ratios (with 1.0 reflecting complete equilibration) for urea, creatinine, inulin, and protein during an eight hour period in which dialysate is allowed to dwell in the peritoneum. Urea equilibration is so rapid that diffusion begins to level off at 90 to 120 minutes and is essentially complete at 240 minutes. Thus, short dwell times will maximize the rate of urea removal. In comparison, larger molecules show a progressive decline in the rate of diffusion. Inulin diffusion, for example, increases linearly with time since a limiting concentration gradient is not approached. As a result, increasing the total time of dialysis enhances the rate of clearance of these larger molecules.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Popovich, RP, Moncrief, JW, Nolph, KD, et al, Ann Intern Med 1978; 88:449.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33198=[""].join("\n");
var outline_f32_26_33198=null;
var title_f32_26_33199="Preauricular pit excision";
var content_f32_26_33199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Preauricular pit excision",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Removal of the preauricular pit should include excision of the pit, the squamous-lined cyst, and the cartilage at the root of the helix en bloc to avoid recurrence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_26_33199=[""].join("\n");
var outline_f32_26_33199=null;
         